Amide compounds, preparation methods and uses thereof

ABSTRACT

Amide compounds, preparation methods and uses thereof. The structure of the compounds is represented as the general formula (I), in which the definitions of substituents are illuminated as description. 
                         
The present amide compounds have broad spectrum activity of killing pests and are effective on lepidopteran pests including  ostrinia nubilalis , sugarcane borer,  adoxophyes orana  fischer von reslerstamm, apple fruit borer,  grapholitha inopinata, lymantri dispar  l.,  cnaphalocrocis medinalis, ostrinia furnacalis, helicoverpa assulta, grapholitha inopinata, plutella xylostella, spodoptera exigua, prodenia litura  etc., especially for  plutella xylostella, spodoptera exigua . The present amide compounds can obtain good effect at very low dosage. At the same time, some compounds have good fungicidal activity which can be used to prevent rice blast,  phytophthora  infestans, cucumber downy mildew or grey mold of vegetables.

FIELD OF THE INVENTION

The present invention relates to insecticide, fungicide. Specifically to amide compounds, preparation methods and uses thereof.

BACKGROUND OF THE INVENTION

The following piperazine compounds with insecticidal and fungicidal activity were known in early U.S. Pat. No. 3,394,137:

-   -   R₁ is selected from alkyl or haloalkyl

The following piperazine compounds with insecticidal and fungicidal activity were known in patent JP2001354657:

Some piperazine compounds with insecticidal and fungicidal activity as agrochemicals were also known in patents, such as JP 2006188462, US 20080076777, CN101128445, US20050032810 and US20030207894.

Some piperazine compounds with pharmaceutical activity were disclosed in patents, such as CN1040029, CN1969853, JP2003335681, U.S. Pat. No. 2,993,062, U.S. Pat. No. 5,872,115, U.S. Pat. No. 6,313,127, US2005119251, US20070027118, US2007004750, US20070190079, US2007219198, WO9728128, WO02102778, WO2004002965, WO2004078732, WO2005023260, WO2006014168. WO2006094843, WO2007009635, WO2007066784, WO2007141039 etc. and references, such as Khimiyai Khimicheskaya Tekhnologiya (2004), 47(8), 91-96; Archiv der Pharmazie (Weinheim, Germany) (2000), 333(10), 323-328.

In addition, the following compounds with fungicidal activity were known in Bayer's patents WO2008003745 and WO2008003746, separately.

Although many piperazine and amide compounds were reported, it's still need to be researched and developed.

SUMMARY OF THE INVENTION

The aim of the present invention is to provide a novel amide compounds, which can be applied to control diseases and insects.

Detailed description of the invention is as follows:

The present invention offered an amide compounds having general formula I:

Wherein:

R₁ and R₂ are selected from H, OH, halogen, CN, NO₂, C₁-C₄alkyl, C₁-C₄haloalkyl, C₁-C₄alkoxyalkyl, COR₁₁, CO₂R₁₁, CONR₁₂R₁₁, C₁-C₄alkoxy, C₁-C₄haloalkoxy, NR₁₂R₁₁, NR₁₂COR₁₁, NR₁₂CO₂R₁₁, SO_(m)R₁₂, SO₂NR₁₂R₁₁, unsubstituted phenyl or substituted phenyl with substituent group(s) being from 1 to 3 in which the substituent group(s) is(are) selected from Cl, Br, F, CN, NO₂, C₁-C₆alkyl, C₁-C₃haloalkyl, C₁-C₃haloalkoxy or C₁-C₃alkoxycarbonyl;

m is selected from 0, 1 or 2;

R₃ and R₄ are selected from H, C₁-C₆alkyl, C₂-C₆alkenyl, C₂-C₆alkynyl, C₃-C₆cycloalkyl or C₁-C₄haloalkyl; or R₃ joined together with R₄ to form 6-8 membered ring;

X is selected from (CHR₅)_(n); n is integers from 2 to 10; R₅ may be the same or different, selected from H, C₁-C₆alkyl, C₂-C₆alkenyl, C₂-C₆alkynyl, C₃-C₆cycloalkyl or C₁-C₆haloalkyl;

G₁ is selected from CR₆ or N; G₂ is selected from CR₇ or N; G₃ is selected from CR₈ or N; but G₁, G₂ and G₃ can not be N at the same time;

R₆, R₇ and R₈ are selected from H, OH, halogen, CN, NO₂, C₁-C₄alkyl, C₃-C₆cycloalkyl, CONH₂, CONHCH₂CN, C₁-C₃alkoxy, C₁-C₃haloalkoxy, C₁-C₃alkylthio, C₁-C₃alkylsulfinyl, C₁-C₃alkylsulfonyl, C₁-C₃alkoxycarbonyl, C₁-C₃alkylcarbonyl, C₁-C₃alkylamino, C₂-C₆dialkylamino, C₃-C₆cycloalkylamino, unsubstituted phenyl or substituted phenyl with substituent group(s) being from 1 to 4, unsubstituted phenylamino or substituted phenylamino with substituent group(s) being from 1 to 4, in which the substituent group(s) is(are) selected from Cl, Br, F, CN, NO₂, C₁-C₄alkyl, C₁-C₃haloalkyl, C₁-C₃alkoxy, C₁-C₃haloalkoxy or C₁-C₃alkoxycarbonyl;

R₉ is selected from H, OH, halogen, CN, NO₂, C₁-C₄alkyl, C₃-C₆cycloalkyl, C₁-C₃haloalkyl, C₁-C₃alkoxyalkyl, C₁-C₃alkoxy, C₁-C₃haloalkoxy, COR₁₁, CO₂R₁₁, CONR₁₁R₁₂, NR₁₂R₁₁, NR₁₂COR₁₁, NR₁₂CO₂R₁₁, SO_(m)R₁₂, SO₂NR₁₂R₁₁, unsubstituted phenyl or substituted phenyl, unsubstituted pyrazolyl or substituted pyrazolyl, unsubstituted pyridyl or substituted pyridyl, in which the substituent group(s) being from 1 to 3 is(are) selected from halogen, CN, NO₂, C₁-C₄alkyl, C₃-C₆cycloalkyl, C₁-C₃haloalkyl, C₁-C₃alkoxyalkyl, C₁-C₃alkoxy, C₁-C₃haloalkoxy, COR₁₁, CO₂R₁₁, CONR₁₁R₁₂, NR₁₁R₁₂, NR₁₂COR₁₁, NR₁₂CO₂R₁₁, SO_(m)R₁₂ or SO₂NR₁₁R₁₂;

t is selected from 1, 2, 3 or 4;

R₁₀ and R₁₁ are selected from H or C₁-C₄alkyl;

R₁₂ is selected from H, C₁-C₄alkyl, C₁-C₃haloalkyl, unsubstituted phenyl or substituted phenyl, in which the substituent group is selected from Cl, Br, F, CN, NO₂, C₁-C₄alkyl, CF₃, OCH₃, OCF₃ or CO₂CH₃;

Q is selected from unsubstituted C₁-C₄alkyl or substituted C₁-C₄alkyl, unsubstituted cyclopropyl or substituted cyclopropyl, wherein the substituent group(s) being from 1 to 4 is(are) selected from Cl, Br, F or C₁-C₄alkyl; unsubstituted phenylamino or substituted phenylamino, unsubstituted C₂-C₄alkenyl or substituted C₂-C₄alkenyl, in which substituent group(s) being from 1 to 3 is(are) selected from Cl, Br, F, C₁-C₄alkyl, C₃-C₆cycloalkyl, C₁-C₄haloalkyl, C₁-C₄alkoxy, C₁-C₄haloalkoxy or C₁-C₄alkoxycarbonyl; unsubstituted phenyl or substituted phenyl, unsubstituted pyrazolyl or substituted pyrazolyl, unsubstituted pyridyl or substituted pyridyl, in which substituent group(s) being from 1 to 4 is(are) halogen, CN, NO₂, C₁-C₄alkyl, C₃-C₆cycloalkyl, C₁-C₃haloalkyl, C₁-C₃alkoxyalkyl, C₁-C₃alkoxy, C₁-C₃haloalkoxy, COR₁₁, CO₂R₁₁, CONR₁₁R₁₂, NR₁₁R₁₂, NR₁₂COR₁₁, NR₁₂CO₂R₁₁, SO_(m)R₁₂ or SO₂NR₁₁R₁₉.

The preferred compounds of general formula I of the invention are:

R₁ is selected from H, OH, Cl, Br, F, NO₂, CN, CH₃, CH₂CH₃, tert-butyl, CF₃, CH₂CF₃, OCH₃, OCF₃, CONH₂, CONHCH₂CN, CO₂CH₃ or CO₂C₂H₅;

R₂ is selected from H, OH, Cl, Br, F, NO₂, CN, CH₃, CH₂CH₃, tert-butyl, cyclopropyl, CF₃, CH₂CF₃, OCF₃, OCH₂CF₃, CO₂CH₃, CO₂C₂H₅, unsubstituted phenyl or substituted phenyl, in which substituent group(s) being from 1 to 3 is(are) Cl, Br, F, CN, NO₂, CH₃, CH₂CH₃, tert-butyl, CF₃, CH₂CF₃, OCH₃, OCF₃, CO₂CH₃ or CO₂C₂H₅;

R₃ and R₄ are selected from H or C₁-C₃alkyl; or R₃ joined together with R₄ to form six-membered ring;

X is selected from (CHR₅)_(n); n is integers selected from 2 to 10; R₅ may be the same or different, selected from H, C₁-C₃alkyl or C₁-C₃haloalkyl;

G₁ is selected from CR₆ or N; G₂ is selected from CR₇ or N; G₃ is selected from CR₈ or N; but G₁, G₂ and G₃ can not be N at the same time;

R₆, R₇ and R₈ are selected from H, OH, Cl, Br, F, CN, NO₂, CH₃, CH₂CH₃, tert-butyl, cyclopropyl, CF₃, CH₂CF₃, OCF₃, OCH₂CF₃, CO₂CH₃, CONH₂, CONHCH₂CN, C₁-C₃alkylamino, C₂-C₄dialkylamino, C₃-C₆cycloalkylamino, unsubstituted phenyl or substituted phenyl with substituent group(s) being from 1 to 3, unsubstituted phenylamino or substituted phenylamino with substituent group(s) being from 1 to 3, wherein the substituent group(s) is(are) selected from Cl, Br, I, CN, NO₂, CH₃, CR₂CH₃, tert-butyl, CHF), CF₃, CH₂CF₃, OCH₃, OCHF₂, OCF₃, CO₂CH₃ or CO₂C₂H₅;

R₉ is selected from H, Cl, Br, F, CN, NO₂, CH₃, tert-butyl, CHF₂, CF₃, OCH₃, OCHF₂, OCF₃, OCH₂CF₃, SO₂CH₃, C₁-C₃alkylamino or C₂-C₄dialkylamino;

t is selected from 1, 2, 3 or 4;

R₁₀ is selected from H, CH₃ or C₂H₅;

NR₁₀—CO-Q is at the 2, 3 or 4-position of benzene ring;

Q is selected from one of the following groups:

Wherein:

R₁₃ is selected from H, Cl, Br, F, CN, NO₂, NH₂, CH₃, CH₂CH₃, tert-butyl, cyclopropyl, CF₃, CH₂CF₃, OCH₃, OCF₃, OCH₂CF₃, SO₂CH₃, CO₂CH₃, C₁-C₃alkylaminocarbonyl, C₂-C₄dialkylaminocarbonyl, unsubstituted phenyl or substituted phenyl with substituent group(s) being from 1 to 3, unsubstituted pyridyl or substituted pyridyl with substituent group(s) being from 1 to 3, the substituent group(s) is(are) selected from H, Cl, Br, F, CN, NO₂, CH₃, CH₂CH₃, tert-butyl, cyclopropyl, CHF₂, CF₃, CH₂CF₃, OCH₃, OCHF₂, OCF₃, OCH₂CF₃ or SO₂CH₃;

R₁₄ is selected from H, CH₃, CH₂CH₃, tert-butyl, CF₃, CH₂CF₃, unsubstituted phenyl or substituted phenyl with substituent group(s) being from 1 to 3, unsubstituted pyridyl or substituted pyridyl with substituent group(s) being from 1 to 3, the substituent group(s) is(are) selected from Cl, Br, F, CN, NO₂, CH₃, CH₂CH₃, tert-butyl, cyclopropyl, CHF₂, CF₃, CH₂CF₃, OCH₃, OCHF₂, OCF₃, OCH₂CF₃ or SO₂CH₃;

p is selected from 1 or 2.

Furthermore, the preferred compounds of general formula I of the invention are:

R₁ is selected from H, Cl, Br, F, NO₂, CN, CH₃, CH₂CH₃, tert-butyl, CF₃, CH₂CF₃, OCH₃, OCF₃, CO₂CH₃ or CO₂C₂H₅;

R₂ is selected from H, Cl, Br, F, NO₂, CN, CH₂CH₃, tert-butyl, cyclopropyl, CF₃, CH₂CF₃, OCF₃, OCH₂CF₃, CO₂CH₃, CO₂C₂H₅, unsubstituted phenyl or substituted phenyl with the substituent group(s) being from 1 to 3 is(are) selected from Cl, Br, F, CN, NO₂, CH₃, CH₂CH₃, tert-butyl, CF₃, CH₂CF₃, OCH₃, OCF₃, CO₂CH₃ or CO₂C₂H₅;

R₃ and R₄ are selected from H or C₁-C₃alkyl; or R₃ joined together with R₄ to form 6 membered ring;

X is selected from (CHR₅)_(n); n is integers selected from 2 to 10; R₅ may be the same or different, selected from H, C₁-C₃alkyl or C₁-C₃haloalkyl;

G₁ is selected from CR₆ or N; G₂ is selected from CR₇ or N; G₃ is selected from CR₈ or N; but G₁, G₂ and G₃ can not be N at the same time;

R₆, R₇ and R₈ are selected from H, Cl, Br, F, CN, NO₂, CH₃, CH₂CH₃, tert-butyl, cyclopropyl, CF₃, CH₂CF₃, OCF₃, OCH₂CF₃, CO₂CH₃, C₁-C₃alkylamino, C₂-C₄dialkylamino, cyclopropylamino, unsubstituted phenyl or substituted phenyl with substituent group(s) being from 1 to 3, unsubstituted phenylamino or substituted phenylamino with substituent group(s) being from 1 to 3, the substituent group(s) is(are) selected from Cl, Br, I, CN, NO₂, CH₃, CH₂CH₃, tert-butyl, CHF₂, CF₃, CH₂CF₃, OCH₃, OCHF₂, OCF₃, CO₂CH₃ or CO₂CH₅;

R₉ is selected from H, Cl, Br, F, CN, NO₂, CH₃, CHF₂, CF₃, OCH₃, OCHF₂, OCF₃, OCH₂CF₃ or SO₂CH₃;

t is selected from 1, 2, 3 or 4;

R₁₀ is selected from H, CH₃ or C₂H₅;

NR₁₀—CO-Q is at the 2, 3 or 4-position of benzene ring;

Q is selected from one of the following groups:

Wherein:

R₁₃ is selected from H, Cl, Br, F, CN, NO₂, CH₃, CH₂CH₃, tert-butyl, cyclopropyl, CF₃, CH₂CF₃, OCH₃, OCF₃, OCH₂CF₃, SO₂CH₃, CO₂CH₃, unsubstituted phenyl or substituted phenyl with substituent group(s) being from 1 to 3, unsubstituted pyridyl or substituted pyridyl with substituent group(s) being from 1 to 3, the substituent group(s) is(are) selected from H, Cl, Br, F, CN, NO₂, CH₃, CH₂CH₃, tert-butyl, cyclopropyl, CHF₂, CF₃, CH₂CF₃, OCH₃, OCHF₂, OCF₃, OCH₂CF₃ or SO₂CH₃;

R₁₄ is selected from H, CH₃, CH₂CH₃, tert-butyl, CF₃, CH₂CF₃, unsubstituted phenyl or substituted phenyl with substituent group(s) being from 1 to 3, unsubstituted pyridyl or substituted pyridyl with substituent group(s) being from 1 to 3-T, the substituent group(s) is(are) selected from Cl, Br, F, CN, NO₂, CH₃, CH₂CH₃, tert-butyl, cyclopropyl, CHF₂, CF₃, CH₂CF₃, OCH₃, OCHF₂, OCF₃, OCH₂CF₃ or SO₂CH₃;

p is selected from 1 or 2.

Even more preferred compounds of general formula I of the invention are:

R₁ is selected from 1-1, Cl, Br, F, NO₂, CN, CH₃, tert-butyl, CF₃, OCH₃ or OCF₃;

R₂ is selected from H, Cl, Br, F, NO₂, CN, CH₃, tert-butyl, cyclopropyl, CF₃, OCF₃, CO₂CH₃ or CO₂C₂H₅;

R₃ and R₄ are selected from H or C₁-C₃alkyl; or R₃ joined together with R₄ to form 6 membered ring;

X is selected from —CH₂CH₂—, —CH₂CH₂CH₂—, —CH(CH₃)CH₂—, —CH(CH₂)₅CH₂—, —CH₂(CH₂)₂CH₂—, —CH₂(CH₂)₃CH₂—, —CH₂(CH₂)₄CH₂—, —CH₂(CH₂)₅CH₂—, —CH₂(CH₂)₆CH₂—, —CH₂(CH₂)₇CH₂— or —CH₂(CH₂)₈CH₂—;

G₁ is selected from CR₆ or N; G₂ is selected from CR₇ or N; G₃ is selected from CR₈ or N; but G₁, G₂ and G₃ can not be N at the same time;

R₆, R₇ and R₈ are selected from H, Cl, Br, F, CN, NO₂, CH₃, CH₂CH₃, tert-butyl, cyclopropyl, CF₃, CH₂CF₃, OCF₃, OCH₂CF₃ or CO₂CH₃;

R₉ is selected from H, Cl, Br, F, CN, NO₂, CH₃, CHF₂, CF₃, OCH₃, OCHF₂, OCF₃, OCH₂CF₃ or SO₂CH₃;

t is selected from 1, 2, 3 or 4;

R₁₀ is selected from H;

NR₁₀—CO-Q is at the 2, 3 or 4-position of benzene ring;

Q is selected from one of the following groups:

Wherein:

R₁₄ is selected from H, CH₃, unsubstituted phenyl or substituted phenyl with substituent group(s) being from 1 to 3, unsubstituted pyridyl or substituted pyridyl with substituent group(s) being from 1 to 3, in which the substituent group(s) is(are) selected from Cl, Br, F, CN, NO₂, CH₃, CH₂CH₃, tert-butyl, CF₃, OCH₃ or OCF₃;

When R₁₄ is selected from H or CH₃, R₄₃ is selected from H, Cl, Br, F, CN, CH₃, CH₂CH₃, tert-butyl, cyclopropyl, CF₃, OCH₃, OCF₃, OCH₂CF₃, SO₂CH₃, unsubstituted phenyl or substituted phenyl, the substituent group is selected from H, Cl, Br, F, CN, NO₂, CH₃, CH₂CH₃, tert-butyl, CHF₂, CF₃, OCH₃, OCHF₂, OCF₃, OCH₂CF₃ or SO₂CH₃;

When R₁₄ is selected from (un)substituted phenyl or pyridyl, R₁₃ is selected from H, Cl, Br, F, CN, CH₃, CH₂CH₃, tert-butyl, cyclopropyl, CF₃, OCF₃, OCH₂CF₃ or SO₂CH₃;

p is selected from 1 or 2.

Most preferred compounds of general formula I of the invention are:

R₁ is selected from H, Cl, Br, F, NO₂, CN, CH₃ or CF₃;

R₂ is selected from 1-1., Cl, Br, F, NO₂, CN, CH₃, tert-butyl, cyclopropyl, CF₃, OCF₃, CO₂CH₃ or CO₂C₂H₅;

R₃ and R₄ are selected from H, or R₃ and R₄ in (R₃)N—X—N(R₄) can join together to form piperazine ring;

X is selected from —CH₂CH₂—, —CH₂CH₂CH₂—, —CH(CH₃)CH₂—, —CH(C₂H₅)CH₂—, —CH₂(CH₂)₂CH₂—, —CH₂(CH₂)₃CH₂—, —CH₂(CH₂)₄CH₂—, —CH₂(CH₂)₅CH₂—, —CH₂(CH₂)₆CH₂—, —CH₂(CH₂)₇CH₂— or —CH₂(CH₂)₈CH₂—;

G₁ is selected from CR₆ or N; G₂ is selected from CR₇ or N; G₃ is selected from CR₈ or N; but G₁, G₂ and G₃ can not be N at the same time;

R₆, R₇ and R₈ are selected from H, Cl, Br, F, CN, NO₂, CH₃, CH₂CH₃, tert-butyl, cyclopropyl, CF₃, OCH₃ or CO₂CH₃;

R₉ is selected from H, Cl, Br, F, CN, NO₂, CH₃, CHF₂, CF₃, OCH₃, OCHF₂, OCF₃, OCH₂CF₃ or SO₂CH₃;

t is selected from 1 or 2;

R₁₀ is selected from H;

NR₁₀—CO-Q is at the 2 or 4-position of benzene ring;

Q is selected from the following pyrazolyl groups:

Wherein:

R₁₄ is selected from H, CH₃, unsubstituted phenyl or substituted phenyl with substituent group(s) being from 1 to 3, unsubstituted pyridyl or substituted pyridyl both with substituent group(s) being from 1 to 3, the substituent group(s) is(are) selected from Cl, Br, F, CN, NO₂, CH₃, CH₂CH₃, tert-butyl, CF₃, OCH₃ or OCF₃;

When R₁₄ is selected from H or CH₃, R₄₃ is selected from H, Cl, Br, F, CN, CH₃, CH₂CH₃, tert-butyl, CF₃, OCH₃, OCF₃, SO₂CH₃, unsubstituted phenyl or substituted phenyl with substituent group, the substituent group is selected from H, Cl, Br, F, CN, NO₂, CH₃, CH₂CH₃, tert-butyl, CHF₂, CF₃, OCH₃, OCHF₂, OCF₃ or SO₂CH₃;

When R₁₄ is selected from (un)substituted phenyl or pyridyl, R₁₃ is selected from H, Cl, Br, F, CN, CH₃, CH₂CH₃, tert-butyl, CF₃, OCH₃, OCF₃ or SO₂CH₃;

p is selected from 1 or 2.

The Q groups of the general formula I in present invention are listed in Table 1:

TABLE 1 Q₁

Q₂

Q₃

Q₄

Q₅

Q₆

Q₇

Q₈

Q₉

Q₁₀

Q₁₁

Q₁₂

Q₁₃

Q₁₄

Q₁₅

Q₁₆

Q₁₇

Q₁₈

Q₁₉

Q₂₀

Q₂₁

Q₂₂

Q₂₃

Q₂₄

Q₂₅

Q₂₆

Q₂₇

Q₂₈

Q₂₉

Q₃₀

Q₃₁

Q₃₂

Q₃₃

Q₃₄

Q₃₅

Q₃₆

Q₃₇

Q₃₈

Q₃₉

Q₄₀

Q₄₁

Q₄₂

Q₄₃

Q₄₄

Q₄₅

Q₄₆

Q₄₇

Q₄₈

Q₄₉

Q₅₀

Q₅₁

Q₅₂

Q₅₃

Q₅₄

Q₅₅

Q₅₆

Q₅₇

Q₅₈

Q₅₉

Q₆₀

Q₆₁

Q₆₂

Q₆₃

Q₆₄

Q₆₅

Q₆₆

Q₆₇

Q₆₈

Q₆₉

Q₇₀

Q₇₁

Q₇₂

Q₇₃

Q₇₄

Q₇₅

Q₇₆

Q₇₇

Q₇₈

Q₇₉

Q₈₀

Q₈₁

Q₈₂

Q₈₃

Q₈₄

Q₈₅

Q₈₆

Q₈₇

Q₈₈

Q₈₉

Q₉₀

Q₉₁

Q₉₂

Q₉₃

Q₉₄

Q₉₅

Q₉₆

Q₉₇

Q₉₈

Q₉₉

Q₁₀₀

Q₁₀₁

Q₁₀₂

Q₁₀₃

Q₁₀₄

Q₁₀₅

Q₁₀₆

Q₁₀₇

Q₁₀₈

Q₁₀₉

Q₁₁₀

Q₁₁₁

Q₁₁₂

Q₁₁₃

Q₁₁₄

Q₁₁₅

Q₁₁₆

Q₁₁₇

Q₁₁₈

Q₁₁₉

Q₁₂₀

Q₁₂₁

Q₁₂₂

Q₁₂₃

Q₁₂₄

Q₁₂₅

Q₁₂₆

Q₁₂₇

Q₁₂₈

Q₁₂₉

Q₁₃₀

Q₁₃₁

Q₁₃₂

Q₁₃₃

Q₁₃₄

Q₁₃₅

Q₁₃₆

Q₁₃₇

Q₁₃₈

Q₁₃₉

Q₁₄₀

Q₁₄₁

Q₁₄₂

Q₁₄₃

Q₁₄₄

Q₁₄₅

Q₁₄₆

Q₁₄₇

Q₁₄₈

Q₁₄₉

Q₁₅₀

Q₁₅₁

Q₁₅₂

Q₁₅₃

Q₁₅₄

Q₁₅₅

Q₁₅₆

Q₁₅₇

Q₁₅₈

Q₁₅₉

Q₁₆₀

Q₁₆₁

Q₁₆₂

Q₁₆₃

Q₁₆₄

Q₁₆₅

Q₁₆₆

Q₁₆₇

Q₁₆₈

Q₁₆₉

Q₁₇₀

Q₁₇₁

Q₁₇₂

Q₁₇₃

Q₁₇₄

Q₁₇₅

Q₁₇₆

Q₁₇₇

Q₁₇₈

Q₁₇₉

Q₁₈₀

Q₁₈₁

Q₁₈₂

Q₁₈₃

Q₁₈₄

Q₁₈₅

Q₁₈₆

Q₁₈₇

Q₁₈₈

Q₁₈₉

Q₁₉₀

Q₁₉₁

Q₁₉₂

Q₁₉₃

Q₁₉₄

Q₁₉₅

Q₁₉₆

Q₁₉₇

Q₁₉₈

Q₁₉₉

Q₂₀₀

Q₂₀₁

Q₂₀₂

Q₂₀₃

Q₂₀₄

Q₂₀₅

Q₂₀₆

Q₂₀₇

Q₂₀₈

Q₂₀₉

Q₂₁₀

When R₉ is selected from H, halogen, CN, CH₃, CF₃, OCH; or OCHF₂, the amide compounds of the general formula I can be defined as formula I-1 to 1-29.

The present invention is also explained by the following compounds in Table 2 to Table 295, but without being restricted thereby.

Table 2: In formula I-1, NR₁₀—CO-Q is at the 2-position, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁, R₂, R₆ and R₇ are H, R₈ is Cl; R₃, R₄, R₅, R₁₀, n and Q are listed in following Table 2.

TABLE 2 No. R₃ R₄ R₅ R₁₀ n Q 1 H H H H 2 Q₆ 2 H H H H 3 Q₁₇₅ 3 H H H H 2 Q₁₆ 4 H H H H 3 Q₁₇₆ 5 H H H H 2 Q₂₀ 6 H H H H 3 Q₁₈₄ 7 H H H H 2 Q₂₁ 8 H H H H 3 Q₁₈₅ 9 H H H H 2 Q₂₄ 10 H H H H 3 Q₁₈₆ 11 H H H H 2 Q₂₅ 12 H H H H 3 Q₁₈₇ 13 H H H H 2 Q₂₆ 14 H H H H 3 Q₁₉₆ 15 H H H H 2 Q₃₀ 16 H H H H 3 Q₁₉₇ 17 H H H H 2 Q₃₁ 18 H H H H 3 Q₁₉₈ 19 H H H H 2 Q₃₂ 20 H H H H 3 Q₁₉₉ 21 H H H H 2 Q₃₄ 22 H H H H 3 Q₂₀₀ 23 H H H H 2 Q₃₅ 24 H H H H 3 Q₂₀₁ 25 H H H H 2 Q₄₀ 26 H H H H 3 Q₂₀₆ 27 H H H H 2 Q₄₆ 28 H H H H 3 Q₂₀₇ 29 H H H H 2 Q₅₉ 30 H H H H 4 Q₆ 31 H H H H 2 Q₆₀ 32 H H H H 4 Q₈₉ 33 H H H H 2 Q₆₁ 34 H H H H 4 Q₉₁ 35 H H H H 2 Q₆₂ 36 H H H H 4 Q₁₁₇ 37 H H H H 2 Q₈₉ 38 H H H H 4 Q₁₆₈ 39 H H H H 2 Q₉₀ 40 H H H H 4 Q₁₆₉ 41 H H H H 2 Q₉₁ 42 H H H H 4 Q₁₇₀ 43 H H H H 2 Q₉₀ 44 H H H H 4 Q₁₈₄ 45 H H H H 2 Q₉₂ 46 H H H H 4 Q₁₈₅ 47 H H H H 2 Q₁₁₄ 48 H H H H 4 Q₁₈₆ 49 H H H H 2 Q₁₁₅ 50 H H H H 4 Q₁₈₇ 51 H H H H 2 Q₁₁₆ 52 H H H H 5 Q₆ 53 H H H H 2 Q₁₁₇ 54 H H H H 5 Q₈₉ 55 H H H H 2 Q₁₂₄ 56 H H H H 5 Q₉₁ 57 H H H H 2 Q₁₂₉ 58 H H H H 5 Q₁₁₇ 59 H H H H 2 Q₁₃₀ 60 H H H H 5 Q₁₆₈ 61 H H H H 2 Q₁₃₁ 62 H H H H 5 Q₁₆₉ 63 H H H H 2 Q₁₄₅ 64 H H H H 5 Q₁₇₀ 65 H H H H 2 Q₁₄₆ 66 H H H H 5 Q₁₈₄ 67 H H H H 2 Q₁₄₇ 68 H H H H 5 Q₁₈₅ 69 H H H H 2 Q₁₄₈ 70 H H H H 5 Q₁₈₆ 71 H H H H 2 Q₁₄₉ 72 H H H H 5 Q₁₈₇ 73 H H H H 2 Q₁₅₀ 74 H H H H 6 Q₆ 75 H H H H 2 Q₁₅₃ 76 H H H H 6 Q₈₉ 77 H H H H 2 Q₁₅₈ 78 H H H H 6 Q₉₁ 79 H H H H 2 Q₁₆₈ 80 H H H H 6 Q₁₁₇ 81 H H H H 2 Q₁₆₉ 82 H H H H 6 Q₁₆₈ 83 H H H H 2 Q₁₇₀ 84 H H H H 6 Q₁₆₉ 85 H H H H 2 Q₁₇₁ 86 H H H H 6 Q₁₇₀ 87 H H H H 2 Q₁₇₄ 88 H H H H 6 Q₁₈₄ 89 H H H H 2 Q₁₇₅ 90 H H H H 6 Q₁₈₅ 91 H H H H 2 Q₁₇₆ 92 H H H H 6 Q₁₈₆ 93 H H H H 2 Q₁₈₄ 94 H H H H 6 Q₁₈₇ 95 H H H H 2 Q₁₈₅ 96 H H H H 7 Q₆ 97 H H H H 2 Q₁₈₆ 98 H H H H 7 Q₈₉ 99 H H H H 2 Q₁₈₇ 100 H H H H 7 Q₉₁ 101 H H H H 2 Q₁₉₆ 102 H H H H 7 Q₁₁₇ 103 H H H H 2 Q₁₉₇ 104 H H H H 7 Q₁₆₈ 105 H H H H 2 Q₁₉₈ 106 H H H H 7 Q₁₆₉ 107 H H H H 2 Q₁₉₉ 108 H H H H 7 Q₁₇₀ 109 H H H H 2 Q₂₀₀ 110 H H H H 7 Q₁₈₄ 111 H H H H 2 Q₂₀₁ 112 H H H H 7 Q₁₈₅ 113 H H H H 2 Q₂₀₆ 114 H H H H 7 Q₁₈₆ 115 H H H H 2 Q₂₀₇ 116 H H H H 7 Q₁₈₇ 117 H H H H 3 Q₆ 118 H H H H 8 Q₆ 119 H H H H 3 Q₁₆ 120 H H H H 8 Q₈₉ 121 H H H H 3 Q₂₀ 122 H H H H 8 Q₉₁ 123 H H H H 3 Q₂₁ 124 H H H H 8 Q₁₁₇ 125 H H H H 3 Q₂₄ 126 H H H H 8 Q₁₆₈ 127 H H H H 3 Q₂₅ 128 H H H H 8 Q₁₆₉ 129 H H H H 3 Q₂₆ 130 H H H H 8 Q₁₇₀ 131 H H H H 3 Q₃₀ 132 H H H H 8 Q₁₈₄ 133 H H H H 3 Q₃₁ 134 H H H H 8 Q₁₈₅ 135 H H H H 3 Q₃₂ 136 H H H H 8 Q₁₈₆ 137 H H H H 3 Q₃₄ 138 H H H H 8 Q₁₈₇ 139 H H H H 3 Q₃₅ 140 H H H H 9 Q₆ 141 H H H H 3 Q₄₀ 142 H H H H 9 Q₈₉ 143 H H H H 3 Q₄₆ 144 H H H H 9 Q₉₁ 145 H H H H 3 Q₅₉ 146 H H H H 9 Q₁₁₇ 147 H H H H 3 Q₆₀ 148 H H H H 9 Q₁₆₈ 149 H H H H 3 Q₆₁ 150 H H H H 9 Q₁₆₉ 151 H H H H 3 Q₆₂ 152 H H H H 9 Q₁₇₀ 153 H H H H 3 Q₈₉ 154 H H H H 9 Q₁₈₄ 155 H H H H 3 Q₉₀ 156 H H H H 9 Q₁₈₅ 157 H H H H 3 Q₉₁ 158 H H H H 9 Q₁₈₆ 159 H H H H 3 Q₉₀ 160 H H H H 9 Q₁₈₇ 161 H H H H 3 Q₉₂ 162 H H H CH₃ 2 Q₆ 163 H H H H 3 Q₁₁₄ 164 H H H CH₃ 2 Q₈₉ 165 H H H H 3 Q₁₁₅ 166 H H H CH₃ 2 Q₉₁ 167 H H H H 3 Q₁₁₆ 168 H H H CH₃ 2 Q₁₁₇ 169 H H H H 3 Q₁₁₇ 170 H H H CH₃ 2 Q₁₆₈ 171 H H H H 3 Q₁₂₄ 172 H H H CH₃ 2 Q₁₆₉ 173 H H H H 3 Q₁₂₉ 174 H H H CH₃ 2 Q₁₇₀ 175 H H H H 3 Q₁₃₀ 176 H H H CH₃ 2 Q₁₈₄ 177 H H H H 3 Q₁₃₁ 178 H H H CH₃ 2 Q₁₈₅ 179 H H H H 3 Q₁₄₅ 180 H H H CH₃ 2 Q₁₈₆ 181 H H H H 3 Q₁₄₆ 182 H H H CH₃ 2 Q₁₈₇ 183 H H H H 3 Q₁₄₇ 184 H H H CH₃ 3 Q₆ 185 H H H H 3 Q₁₄₈ 186 H H H CH₃ 3 Q₈₉ 187 H H H H 3 Q₁₄₉ 188 H H H CH₃ 3 Q₉₁ 189 H H H H 3 Q₁₅₀ 190 H H H CH₃ 3 Q₁₁₇ 191 H H H H 3 Q₁₅₃ 192 H H H CH₃ 3 Q₁₆₈ 193 H H H H 3 Q₁₅₈ 194 H H H CH₃ 3 Q₁₆₉ 195 H H H H 3 Q₁₆₈ 196 H H H CH₃ 3 Q₁₇₀ 197 H H H H 3 Q₁₆₉ 198 H H H CH₃ 3 Q₁₈₄ 199 H H H H 3 Q₁₇₀ 200 H H H CH₃ 3 Q₁₈₅ 201 H H H H 3 Q₁₇₁ 202 H H H CH₃ 3 Q₁₈₆ 203 H H H H 3 Q₁₇₄ 204 H H H CH₃ 3 Q₁₈₇ 205 H H H H 2 Q₁₆₆ 206 H H H H 3 Q₁₆₆ 207 H H H H 2 Q₁₇₃ 208 H H H H 3 Q₁₇₃ 209 H H H H 2 Q₁₇₇ 210 H H H H 3 Q₁₇₇ 211 H H H H 2 Q₁₇₈ 212 H H H H 3 Q₁₇₈ 213 H H H H 2 Q₁₇₉ 214 H H H H 3 Q₁₇₉ 215 H H H H 2 Q₁₈₀ 216 H H H H 3 Q₁₈₀ 217 H H H H 2 Q₁₈₁ 218 H H H H 3 Q₁₈₁ 219 H H H H 2 Q₁₈₂ 220 H H H H 3 Q₁₈₂     No.

    R₁₀     Q 221

H Q₆ 222

H Q₆ 223

H Q₁₆ 224

H Q₁₆ 225

H Q₂₀ 226

H Q₂₀ 227

H Q₂₁ 228

H Q₂₁ 229

H Q₂₄ 230

H Q₂₄ 231

H Q₂₅ 232

H Q₂₅ 233

H Q₂₆ 234

H Q₂₆ 235

H Q₃₀ 236

H Q₃₀ 237

H Q₃₁ 238

H Q₃₁ 239

H Q₃₂ 240

H Q₃₂ 241

H Q₃₄ 242

H Q₃₄ 243

H Q₃₅ 244

H Q₃₅ 245

H Q₄₀ 246

H Q₄₀ 247

H Q₄₆ 248

H Q₄₆ 249

H Q₅₉ 250

H Q₅₉ 251

H Q₆₀ 252

H Q₆₀ 253

H Q₆₁ 254

H Q₆₁ 255

H Q₆₂ 256

H Q₆₂ 257

H Q₈₉ 258

H Q₈₉ 259

H Q₉₀ 260

H Q₉₀ 261

H Q₉₁ 262

H Q₉₁ 263

H Q₉₀ 264

H Q₉₀ 265

H Q₉₂ 266

H Q₉₂ 267

H Q₁₁₄ 268

H Q₁₁₄ 269

H Q₁₁₅ 270

H Q₁₁₅ 271

H Q₁₁₆ 272

H Q₁₁₆ 273

H Q₁₁₇ 274

H Q₁₁₇ 275

H Q₁₂₄ 276

H Q₁₂₄ 277

H Q₁₂₉ 278

H Q₁₂₉ 279

H Q₁₃₀ 280

H Q₁₃₀ 281

H Q₁₃₁ 282

H Q₁₃₁ 283

H Q₁₄₅ 284

H Q₁₄₅ 285

H Q₁₄₆ 286

H Q₁₄₆ 287

H Q₁₄₇ 288

H Q₁₄₇ 289

H Q₁₄₈ 290

H Q₁₄₈ 291

H Q₁₄₉ 292

H Q₁₄₉ 293

H Q₁₅₀ 294

H Q₁₅₀ 295

H Q₁₅₃ 296

H Q₁₅₃ 297

H Q₁₅₈ 298

H Q₁₅₈ 299

H Q₁₆₈ 300

H Q₁₆₈ 301

H Q₁₆₉ 302

H Q₁₆₉ 303

H Q₁₇₀ 304

H Q₁₇₀ 305

H Q₁₇₁ 306

H Q₁₇₁ 307

H Q₁₇₄ 308

H Q₁₇₄ 309

H Q₁₇₅ 310

H Q₁₇₅ 311

H Q₁₇₆ 312

H Q₁₇₆ 313

H Q₁₈₄ 314

H Q₁₈₄ 315

H Q₁₈₅ 316

H Q₁₈₅ 317

H Q₁₈₆ 318

H Q₁₈₆ 319

H Q₁₈₇ 320

H Q₁₈₇ 321

H Q₁₉₆ 322

H Q₁₉₆ 323

H Q₁₉₇ 324

H Q₁₉₇ 325

H Q₁₉₈ 326

H Q₁₉₈ 327

H Q₁₉₉ 328

H Q₁₉₉ 329

H Q₂₀₀ 330

H Q₂₀₀ 331

H Q₂₀₁ 332

H Q₂₀₁ 333

H Q₂₀₆ 334

H Q₂₀₆ 335

H Q₂₀₇ 336

H Q₂₀₇

Table 3: Wherein for formula I-1, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁, R₂, R₆ and R₇ are H, R₈ is Cl; R₃, R₄, R₅, R₁₀, n and Q in Table 3 are the same as that of Table 2.

Table 4: Wherein for formula I-1, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁, R₂, R₆ and R₇ are 1-1, R₈ is CN; R₃, R₄, R₅, R₁₀, n and Q in Table 4 are the same as that of Table 2.

Table 5: Wherein for formula I-1, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁, R₂, R₆ and R₇ are H, R₈ is CN; R₃, R₄, R₅, R₁₀, n and Q in Table 5 are the same as that of Table 2.

Table 6: Wherein for formula I-1, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂, R₆ and R₇ are H, R₁ is Cl, R₈ is CF₃; R₃, R₄, R₅, R₁₀, n and Q in Table 6 are the same as that of Table 2.

Table 7: Wherein for formula I-1, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂, R₆ and R₇ are I-1, R₁ is Cl, R₈ is CF₃; R₃, R₄, R₅, R₁₀, n and Q in Table 3 are the same as that of Table 2.

Table 8: Wherein for formula I-1, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂, R₆ and R₇ are H, R₁ is NO₂, R₈ is CF₃; R₃, R₄; R₅, R₁₀, n and Q in Table 8 are the same as that of Table 2.

Table 9: Wherein for formula I-1, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂, R₆ and R₇ are H, R₁ is NO₂, R₈ is CF₃; R₃, R₄, R₅, R₁₀, n and Q in Table 9 are the same as that of Table 2.

Table 10: Wherein for formula I-1, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂ and R₇ are H, R₁ and R₆ are Cl, R₈ is CF₃; R₃, R₄, R₅, R₁₀, n and Q in Table 3 are the same as that of Table 2.

Table 11: Wherein for formula I-1, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂ and R₇ are H, R₁ and R₆ are Cl, R₈ is CF₃; R₃, R₄, R₅, R₁₀, n and Q in Table 11 are the same as that of Table 2.

Table 12: Wherein for formula I-1, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂ and R₇ are H, R₁ and R₆ are NO₂, R₈ is CF₃; R₃, R₄, R₅, R₁₀, n and Q in Table 12 are the same as that of Table 2.

Table 13: Wherein for formula I-1, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂ and R₇ are H, R₁ and R₆ are NO₂, R₈ is CF₃; R₃, R₄, R₅, R₁₀, n and Q in Table 13 are the same as that of Table 2.

Table 14: Wherein for formula I-1, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂ and R₇ are H, R₁ and R₆ are Cl, R₈ is CN; R₃, R₄, R₅, R₁₀, n and Q in Table 14 are the same as that of Table 2.

Table 15: Wherein for formula I-1, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂ and R₇ are H, R₁ and R₆ are Cl, R₈ is CN; R₃, R₄, R₅, R₁₀, n and Q in Table 15 are the same as that of Table 2.

Table 16: Wherein for formula I-1, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ and R₆ are NO₂, R₂ is C₁, R₇ is H, R₈ is CF₃; R₃, R₄, R₅, R₁₀, n and Q in Table 16 are the same as that of Table 2.

Table 17: Wherein for formula I-1, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ and R₆ are NO₂, R₂ is C₁, R₇ is H, R₈ is CF₃; R₃, R₄, R₅, R₁₀, n and Q in Table 17 are the same as that of Table 2.

Table 18: Wherein for formula I-1, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is C₁, R₂, R₇ and R₈ are H; R₃, R₄, R₅, R₁₀, n and Q in Table 18 are the same as that of Table 2.

Table 19: Wherein for formula I-1, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is C₁, R₂, R₇ and R₈ are H; R₃, R₄, R₅, R₁₀, n and Q in Table 19 are the same as that of Table 2.

Table 20: Wherein for formula I-1, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₈ is CF₃, R₄, R₂ and R₇ are H; R₃, R₄, R₅, R₁₀, n and Q in Table 20 are the same as that of Table 2.

Table 21: Wherein for formula I-1, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₈ is CF₃, R₄, R₂ and R₇ are H; R₃, R₄, R₅, R₁₀, n and Q in Table 21 are the same as that of Table 2.

Table 22: Wherein for formula I-1, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is Cl, R₈ is CF₃, R₂ and R₇ are H; R₃, R₄, R₅, R₁₀, n and Q in Table 22 are the same as that of Table 2.

Table 23: Wherein for formula I-1, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is Cl, R₈ is CF₃, R₂ and R₇ are H; R₃, R₄, R₅, R₁₀, n and Q in Table 23 are the same as that of Table 2.

Table 24: Wherein for formula I-1, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is Cl, R₈ is CN, R₂ and R₇ are H; R₃, R₄, R₅, R₁₀, n and Q in Table 24 are the same as that of Table 2.

Table 25: Wherein for formula I-1, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)₁₁, R₁ is Cl, R₈ is CN, R₂ and R₇ are H; R₃, R₄, R₅, R₁₀, n and Q in Table 25 are the same as that of Table 2.

Table 26: Wherein for formula I-1, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is H, R₇ is CF₃, R₇ is Cl, R₈ is CN; R₃, R₄, R₅, R₁₀, n and Q in Table 26 are the same as that of Table 2.

Table 27: Wherein for formula I-1, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ is N, C) is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is H, R₂ is CF₃, R₇ is Cl, R₈ is CN; R₃, R₄, R₅, R₁₀, n and Q in Table 27 are the same as that of Table 2.

Table 28: Wherein for formula I-1, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is H, R₂ is CH₃, R₇ is Cl, R₈ is CN; R₃, R₄, R₅, R₁₀, n and Q in Table 28 are the same as that of Table 2.

Table 29: Wherein for formula I-1, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is H, R₂ is CH₃, R₇ is Cl, R₈ is CN; R₃, R₄, R₅, R₁₀, n and Q in Table 29 are the same as that of Table 2.

Table 30: Wherein for formula I-1, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is CN, R₂ is CH₃, R₇ is CH₃, R₈ is H; R₃, R₄, R₅, R₁₀, n and Q in Table 30 are the same as that of Table 2.

Table 31: Wherein for formula I-1, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is CN, R₂ is CH₃, R₇ is CH₃, R₈ is H; R₃, R₄, R₅, R₁₀, n and Q in Table 31 are the same as that of Table 2.

Table 32: Wherein for formula I-1, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is C₁, R₂ is CH₃, R₇ is CH₃, R₈ is H; R₃, R₄, R₅, R₁₀, n and Q in Table 32 are the same as that of Table 2.

Table 33: Wherein for formula I-1, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is C₁, R₂ is H, R₇ and R₈ are Cl; R₃, R₄, R₅, R₁₀, n and Q in Table 33 are the same as that of Table 2.

Table 34: Wherein for formula I-1, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is Cl, R₁ is CH₃, R₇ is H; R₃, R₄, R₅, R₁₀, n and Q in Table 34 are the same as that of Table 2.

Table 35: Wherein for formula I-1, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is C₁, R₂ is CH₃, R₇ is H; R₃, R₄, R₅, R₁₀, n and Q in Table 35 are the same as that of Table 2.

Table 36: Wherein for formula I-1, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CF₃, R₇ is CH(CH₃)₂O; R₃, R₄, R₅, R₁₀, n and Q in Table 36 are the same as that of Table 2.

Table 37: Wherein for formula I-1, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CF₃, R₇ is CH(CH₃)₂O; R₃, R₄, R₅, R₁₀, n and Q in Table 37 are the same as that of Table 2.

Table 38: Wherein for formula I-1, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CF₃, R₇ is cyclopropyl; R₃, R₄, R₅, R₁₀, n and Q in Table 38 are the same as that of Table 2.

Table 39: Wherein for formula I-1, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CF₃, R₇ is cyclopropyl; R₃, R₄, R₅, R₁₀, n and Q in Table 39 are the same as that of Table 2.

Table 40: Wherein for formula I-1, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is CH₃, R₂ is Ph, R₇ is CH₃; R₃, R₄, R₅, R₁₀, n and Q in Table 40 are the same as that of Table 2.

Table 41: Wherein for formula I-1, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is CH₃, R₂ is Ph, R₇ is CH₃; R₃, R₄, R₅, R₁₀, n and Q in Table 41 are the same as that of Table 2.

Table 42: Wherein for formula I-1, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is CH₃R₂ is 4-Cl-Ph, R₇ is CH₃; R₃, R₄, R₅, R₁₀, n and Q in Table 42 are the same as that of Table 2.

Table 43: Wherein for formula I-1, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is CH₃, R₂ is 4-Cl-Ph, R₇ is CH₃; R₃, R₄, R₅, R₁₀, n and Q in Table 43 are the same as that of Table 2.

Table 44: Wherein for formula I-1, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is CH₃, G₂ is 4-CH₃O-Ph, R₇ is CH₃; R₃, R₄, R₅, R₁₀, n and Q in Table 44 are the same as that of Table 2.

Table 45: Wherein for formula I-1, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is CH₃, R₂ is 4-CH₃O-Ph, R₇ is CH₃; R₃, R₄, R₅, R₁₀, n and Q in Table 45 are the same as that of Table 2.

Table 46: Wherein for formula I-1, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ and R₇ are H, R₂ is Cl; R₃, R₄, R₅, R₁₀, n and Q in Table 46 are the same as that of Table 2.

Table 47: Wherein for formula I-1, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ and R₇ are H, R₂ is Cl; R₃, R₄, R₅, R₁₀, n and Q in Table 47 are the same as that of Table 2.

Table 48: Wherein for formula I-1, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is F, R₂ is C₁, R₇ is H; R₃, R₄, R₅, R₁₀, n and Q in Table 48 are the same as that of Table 2.

Table 49: Wherein for formula I-1, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is F, R₂ is C₁, R₇ is H; R₃, R₄, R₅, R₁₀, n and Q in Table 49 are the same as that of Table 2.

Table 50: Wherein for formula I-1, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CH₃, R₇ is CH₃O; R₃, R₄, R₅, R₁₀, n and Q in Table 50 are the same as that of Table 2.

Table 51: Wherein for formula I-1, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CH₃, R₇ is CH₃O; R₃, R₄, R₅, R₁₀, n and Q in Table 51 are the same as that of Table 2.

Table 52: Wherein for formula I-1, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CH₃, R₇ is (C₂H₅)₂N; R₃, R₄, R₅, R₁₀, n and Q in Table 52 are the same as that of Table 2.

Table 53: Wherein for formula I-1, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CH₃, R₇ is (C₂H₅)₂N; R₃, R₄, R₅, R₁₀, n and Q in Table 53 are the same as that of Table 2.

Table 54: Wherein for formula I-1, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CF₃, R₇ is CH₃O; R₃, R₄, R₅, R₁₀, n and Q in Table 54 are the same as that of Table 2.

Table 55: Wherein for formula I-1, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CF₃, R₇ is CH₃O; R₃, R₄, R₅, R₁₀, n and Q in Table 55 are the same as that of Table 2.

Table 56: Wherein for formula I-1, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CF₃, R₇ is (C₂H₅)₂N; R₃, R₄, R₅, R₁₀, n and Q in Table 56 are the same as that of Table 2.

Table 57: Wherein for formula I-1, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CF₃, R₇ is (C₂H₅)₂N; R₃, R₄, R₅, R₁₀, n and Q in Table 57 are the same as that of Table 2.

Table 58: Wherein for formula I-1, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CH₃, R₇ is CH₃CH₂CH₂; R₃, R₄, R₅, R₁₀, n and Q in Table 58 are the same as that of Table 2.

Table 59: Wherein for formula I-1, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CH₃, R₇ is CH₃CH₂CH₂; R₃, R₄, R₅, R₁₀, n and Q in Table 59 are the same as that of Table 2.

Table 60: Wherein for formula I-1, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is C₄H₉, R₂ is CH₃, R₇ is (C₂H₅)₂N; R₃, R₄, R₅, R₁₀, n and Q in Table 60 are the same as that of Table 2.

Table 61: Wherein for formula I-1, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is C₄H₉, R₂ is CH₃, R₇ is (C₂H₅)₂N; R₃, R₄, R₅, R₁₀, n and Q in Table 61 are the same as that of Table 2.

Table 62: Wherein for formula I-1, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is C₄H₉, R₂ is CH₃, R₇ is C₂H₅NH; R₃, R₄, R₅, R₁₀, n and Q in Table 62 are the same as that of Table 2.

Table 63: Wherein for formula I-1, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is C₄H₉, R₂ is CH₃, R₇ is C₂H₅NH; R₃, R₄, R₅, R₁₀, n and Q in Table 63 are the same as that of Table 2.

Table 64: Wherein for formula I-1, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CH₃, R₇ is Ph-NH; R₃, R₄, R₅, R₁₀, n and Q in Table 64 are the same as that of Table 2.

Table 65: Wherein for formula I-1, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CH₃, R₇ is Ph-NH; R₃, R₄, R₅, R₁₀, n and Q in Table 65 are the same as that of Table 2.

Table 66: Wherein for formula I-1, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CF₃, R₇ is 4-Cl-Ph-NH; R₃, R₄, R₅, R₁₀, n and Q in Table 66 are the same as that of Table 2.

Table 67: Wherein for formula I-1, NR₁₀—CO-Q is at the 4-position of benzene ring. G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CF₃, R₇ is 4-Cl-Ph-NH; R₃, R₄, R₅, R₁₀, n and Q in Table 67 are the same as that of Table 2.

Table 68: Wherein for formula I-1, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CF₃, R₇ is Ph-NH; R₃, R₄, R₅, R₁₀, n and Q in Table 68 are the same as that of Table 2.

Table 69: Wherein for formula I-1, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CF₃, R₇ is Ph-NH; R₃, R₄, R₅, R₁₀, n and Q in Table 69 are the same as that of Table 2.

Table 70: Wherein for formula I-1, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, Cl₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₇ is CH₃, R₇ is 4-Cl-Ph-NH; R₃, R₄, R₅, R₁₀, n and Q in Table 70 are the same as that of Table 2.

Table 71: Wherein for formula I-1, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CH₃, R₇ is 4-Cl-Ph-NH; R₃, R₄, R₅, R₁₀, n and Q in Table 71 are the same as that of Table 2.

Table 72: Wherein for formula I-1, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₂ are N, G₃ is CR₈, X═(CHR₅)_(n), R₁ and R₂ are F₁, R₈ is Cl; R₃, R₄, R₅, R₁₀, n and Q in Table 72 are the same as that of Table 2.

Table 73: Wherein for formula I-1, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ and G₂ are N, G₃ is CR₈, X═(CHR₅)_(n), R₁ and R₂ are H, R₈ is Cl; R₃, R₄, R₅, R₁₀, n and Q in Table 73 are the same as that of Table 2.

Table 74: Wherein for formula I-1, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₂ are N, G₃ is CR₈, X═(CHR₅)_(n), R₁, R₂ and R₈ are N; R₃, R₄, R₅, R₁₀, n and Q in Table 74 are the same as that of Table 2.

Table 75: Wherein for formula I-1, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ and 07 are N, G₃ is CR₈, X═(CHR₅)_(n), R₁, R₂ and R₈ are H; R₃, R₄, R₅, R₁₀, n and Q in Table 75 are the same as that of Table 2.

Table 76: Wherein for formula I-1, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₂ are N, G₃ is CR₈, X═(CHR₅)_(n), R₁ and R₂ are H, R₈ is Ph; R₃, R₄, R₅, R₁₀, n and Q in Table 76 are the same as that of Table 2.

Table 77: Wherein for formula I-1, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ and G₂ are N, G₃ is CR₈, X═(CHR₅)_(n), R₁ and R₂ are H, R₈ is Ph; R₃, R₄, R₅, R₁₀, n and Q in Table 77 are the same as that of Table 2.

Table 78: Wherein for formula I-1, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁, R₆, R₇ and R₈ are H, R₂ is C(CH₃)₃; R₃, R₄, R₅, R₁₀, n and Q in Table 78 are the same as that of Table 2.

Table 79: Wherein for formula I-1, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁, R₆, R₇ and R₈ are H, R₂ is C(CH₃)₃; R₃, R₄, R₅, R₁₀, n and Q in Table 79 are the same as that of Table 2.

Table 80: Wherein for formula I-1, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ and R₇ are C₁, R₂ is H, R₈ is CF₃; R₃, R₄, R₅, R₁₀, n and Q in Table 80 are the same as that of Table 2.

Table 81: Wherein for formula I-1, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ and R₇ are C₁, R₂ is H, R₈ is CF₃; R₃, R₄, R₅, R₁₀, n and Q in Table 81 are the same as that of Table 2.

Table 82: Wherein for formula I-1, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂ and R₇ are H, R₁ and R₈ are Cl; R₃, R₄, R₅, R₁₀, n and Q in Table 82 are the same as that of Table 2.

Table 83: Wherein for formula I-1, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂ and R₇ are H, R₁ and R₈ are Cl; R₃, R₄, R₅, R₁₀, n and Q in Table 83 are the same as that of Table 2.

Table 84: Wherein for formula I-1, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂ and R₇ are H, R₁ is Cl, R₈ is CH₃; R₃, R₄, R₅, R₁₀, n and Q in Table 84 are the same as that of Table 2.

Table 85: Wherein for formula I-1, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂ and R₇ are H, R₁ is Cl, R₈ is CH₃; R₃, R₄, R₅, R₁₀, n and Q in Table 85 are the same as that of Table 2.

Table 86: Wherein for formula I-13, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁, R₂, R₆ and R₇ are H, R₃ is Cl; R₃, R₄, R₅, R₁₀, n and Q in Table 86 are the same as that of Table 2.

Table 87: Wherein for formula I-13, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁, R₂, R₆ and R₇ are H, R₈ is Cl; R₃, R₄, R₅, R₁₀, n and Q in Table 87 are the same as that of Table 2.

Table 88: Wherein for formula I-13, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂, R₆ and R₇ are H, R₁ is Cl; R₈ is CF₃, R₃, R₄, R₅, R₁₀, n and Q in Table 88 are the same as that of Table 2.

Table 89: Wherein for formula I-13, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂, R₆ and R₇ are H, R₁ is NO₂, R₈ is CF₃; R₃, R₄, R₅, R₁₀, n and Q in Table 89 are the same as that of Table 2.

Table 90: Wherein for formula I-13, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂ and R₇ are H, R₁, and R₆ are Cl, R₈ is CF₃; R₃, R₄, R₅, R₁₀, n and Q in Table 90 are the same as that of Table 2.

Table 91: Wherein for formula I-13, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂ and R₇ are H, R₁ and R₆ are NO₂, R₈ is CF₃; R₃, R₄, R₅, R₁₀, n and Q in Table 91 are the same as that of Table 2.

Table 92: Wherein for formula I-13, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂ and R₇ are H, R₁ and R₆ are Cl, R₈ is CN; R₃, R₄, R₅, R₁₀, n and Q in Table 92 are the same as that of Table 2.

Table 93: Wherein for formula I-13, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ and R₆ are NO₂, R₂ is C₁, R₇ is H, R₈ is CF₃; R₃, R₄, R₅, R₁₀, n and Q in Table 93 are the same as that of Table 2.

Table 94: Wherein for formula I-13, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is C₁, R₂, R₇ and R₈ are H; R₃, R₄, R₅, R₁₀, n and Q in Table 94 are the same as that of Table 2.

Table 95: Wherein for formula I-13, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₈ is CF₃, R₄, R) and R₇ are H; R₃, R₄, R₅, R₁₀, n and Q in Table 95 are the same as that of Table 2.

Table 96: Wherein for formula I-13, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is Cl, R₈ is CN, R₂ and R₇ are H; R₃, R₄, R₅, R₁₀, n and Q in Table 96 are the same as that of Table 2.

Table 97: Wherein for formula I-13, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is Cl, R₈ is CN, R₂ and R₇ are H; R₃, R₄, R₅, R₁₀, n and Q in Table 97 are the same as that of Table 2.

Table 98: Wherein for formula I-13, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is H, R₂ is CF₃, R₇ is Cl, R₈ is CN; R₃, R₄, R₅, R₁₀, n and Q in Table 98 are the same as that of Table 2.

Table 99: Wherein for formula I-13, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is H, R₂ is CH₃, R₇ is Cl, R₈ is CN; R₃, R₄, R₅, R₁₀, n and Q in Table 99 are the same as that of Table 2.

Table 100: Wherein for formula I-13, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is CN, R₂ is CH₃, R₇ is CH₃, R₈ is H; R₃, R₄, R₅, R₁₀, n and Q in Table 100 are the same as that of Table 2.

Table 101: Wherein for formula I-13, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is C₁, R₂ is H, R₇ and R₈ are Cl; R₃, R₄, R₅, R₁₀, n and Q in Table 101 are the same as that of Table 2.

Table 102: Wherein for formula I-13, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is C₁, R₂ is CH₃, R₇ is H; R₃, R₄, R₅, R₁₀, n and Q in Table 102 are the same as that of Table 2.

Table 103: Wherein for formula I-13, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CF₃, R₇ is CH(CH₃)₂O; R₃, R₄, R₅, R₁₀, n and Q in Table 103 are the same as that of Table 2.

Table 104: Wherein for formula I-13, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CF₃, R₇ is cyclopropyl; R₃, R₄, R₅, R₁₀, n and Q in Table 104 are the same as that of Table 2.

Table 105: Wherein for formula I-13, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is CH₃, R₂ is Ph, R₇ is CH₃; R₃, R₄, R₅, R₁₀, n and Q in Table 105 are the same as that of Table 2.

Table 106: Wherein for formula I-13, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is CH₃, R₂ is 4-Cl-Ph, R₇ is CH₃; R₃, R₄, R₅, R₁₀, n and Q in Table 106 are the same as that of Table 2.

Table 107: Wherein for formula I-13, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is CH₃, R₂ is 4-CH₃O-Ph, R₇ is CH₃; R₃, R₄, R₅, R₁₀, n and Q in Table 107 are the same as that of Table 2.

Table 108: Wherein for formula I-13, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ and R₇ are H, R₂ is Cl; R₃, R₄, R₅, R₁₀, n and Q in Table 108 are the same as that of Table 2.

Table 109: Wherein for formula I-13, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is F, R₂ is C₁, R₇ is H; R₃, R₄, R₅, R₁₀, n and Q in Table 109 are the same as that of Table 2.

Table 110: Wherein for formula I-13, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CH₃, R₇ is CH₃O; R₃, R₄, R₅, R₁₀, n and Q in Table 110 are the same as that of Table 2.

Table 111: Wherein for formula I-13, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CH₃, R₇ is (C₂H₅)₂N; R₃, R₄, R₅, R₁₀, n and Q in Table 111 are the same as that of Table 2.

Table 112: Wherein for formula I-13, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CF₃, R₇ is CH₃O; R₃, R₄, R₅, R₁₀, n and Q in Table 112 are the same as that of Table 2.

Table 113: Wherein for formula I-13, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CF₃, R₇ is (C₂H₅)₂N; R₃, R₄, R₅, R₁₀, n and Q in Table 113 are the same as that of Table 2.

Table 114: Wherein for formula I-13, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CH₃, R₇ is CH₃CH₂CH₂; R₃, R₄, R₅, R₁₀, n and Q in Table 114 are the same as that of Table 2.

Table 115: Wherein for formula I-13, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is C₄H₉, R₂ is CH₃, R₇ is (C₂H₅)₂N; R₃, R₄, R₅, R₁₀, n and Q in Table 115 are the same as that of Table 2.

Table 116: Wherein for formula I-13, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is C₄H₉, R₂ is CH₃, R₇ is C₂H₅NH; R₃, R₄, R₅, R₁₀, n and Q in Table 116 are the same as that of Table 2.

Table 117: Wherein for formula I-13, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CH₃, R₇ is Ph-NH; R₃, R₄, R₅, R₁₀, n and Q in Table 117 are the same as that of Table 2.

Table 118: Wherein for formula I-13, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CF₃, R₇ is 4-Cl-Ph-NH; R₃, R₄, R₅, R₁₀, n and Q in Table 118 are the same as that of Table 2.

Fable 119: Wherein for formula I-13, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CF₃, R₇ is Ph-NH; R₃, R₄, R₅, R₁₀, n and Q in Table 119 are the same as that of Table 2.

Table 120: Wherein for formula I-13, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CH₃, R₇ is 4-Cl-Ph-NH; R₃, R₄, R₅, R₁₀, n and Q in Table 120 are the same as that of Table 2.

Table 121: Wherein for formula I-13, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ and G₂ are N, G₃ is CR₈, X═(CHR₅)_(n), R₁ and R₇ are H, R₈ is Cl; R₃, R₄, R₅, R₁₀, n and Q in Table 121 are the same as that of Table 2.

Table 122: Wherein for formula I-13, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ and G₂ are N, G₃ is CR₈, X═(CHR₅)_(n), R₁, R₂ and R₈ are H; R₃, R₄, R₅, R₁₀, n and Q in Table 122 are the same as that of Table 2.

Table 123: Wherein for formula I-13, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ and G₂ are N, G₃ is CR₈, X═(CHR₅)_(n), R₁ and R₂ are H, R₈ is Ph; R₃, R₄, R₅, R₁₀, n and Q in Table 123 are the same as that of Table 2.

Table 124: Wherein for formula I-13, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁, R₆, R₇ and R₈ are H, R₂ is C(CH₃)₃; R₃, R₄, R₅, R₁₀, n and Q in Table 124 are the same as that of Table 2.

Table 125: Wherein for formula I-13, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂ and R₇ are H, R₁ is Cl, R₈ is CH₃; R₃, R₄, R₅, R₁₀, n and Q in Table 125 are the same as that of Table 2.

Table 126: Wherein for formula I-13, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂ and R₇ are H, R₁ and R₈ are Cl; R₃, R₄, R₅, R₁₀, n and Q in Table 126 are the same as that of Table 2.

Table 127: Wherein for formula I-13, NR₁₀—CO-Q is at the 4-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂ and R₇ are H, R₁ and R₈ are Cl; R₃, R₄, R₅, R₁₀, n and Q in Table 127 are the same as that of Table 2.

Table 128: Wherein for formula I-18, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁, R₂, R₆ and R₇ are H, R₈ is Cl; R₃, R₄, R₅, R₁₀, n and Q in Table 128 are the same as that of Table 2.

Table 129: Wherein for formula I-18, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁, R₂, R₆ and R₇ are H, R₈ is CN; R₃, R₄, R₅, R₁₀, n and Q in Table 129 are the same as that of Table 2.

Table 130: Wherein for formula I-18, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁, R₂, R₆ and R₇ are H, R₈ is CF₃; R₃, R₄, R₅, R₁₀, n and Q in Table 130 are the same as that of Table 2.

Table 131: Wherein for formula I-18, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂, R₆ and R₇ are H, R₁ is Cl, R₈ is CF₃; R₃, R₄, R₅, R₁₀, n and Q in Table 131 are the same as that of Table 2.

Table 132: Wherein for formula I-18, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂, R₆ and R₇ are H, R₁ is NO₂, R₈ is CF₃; R₃, R₄, R₅, R₁₀, n and Q in Table 132 are the same as that of Table 2.

Table 133: Wherein for formula I-18, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂ and R₇ are H, R₁ and R₆ are Cl, R₈ is CF₃; R₃, R₄, R₅, R₁₀, n and Q in Table 133 are the same as that of Table 2.

Table 134: Wherein for formula I-18, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂ and R₇ are 14, R₁ and R₆ are NO₂, R₈ is CF₃; R₃, R₄, R₅, R₁₀, n and Q in Table 134 are the same as that of Table 2.

Table 135: Wherein for formula I-18, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂ and R₇ are H, R₁ and R₆ are Cl, R₈ is CN; R₃, R₄, R₅, R₁₀, n and Q in Table 135 are the same as that of Table 2.

Table 136: Wherein for formula I-18, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ and R₆ are NO₂, R₂ is C₁, R₇ is H, R₈ is CF₃; R₃, R₄, R₅, R₁₀, n and Q in Table 136 are the same as that of Table 2.

Table 137: Wherein for formula I-18, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is C₁, R₂, R₇ and R₈ are H; R₃, R₄, R₅, R₁₀, n and Q in Table 137 are the same as that of Table 2.

Table 138: Wherein for formula I-18, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₈ is CF₃, R₄, R₂ and R₇ are H; R₃, R₄, R₅, R₁₀, n and Q in Table 138 are the same as that of Table 2.

Table 139: Wherein for formula I-18, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is Cl, R₈ is CF₃, R₂ and R₇ are H; R₃, R₄, R₅, R₁₀, n and Q in Table 139 are the same as that of Table 2.

Table 140: Wherein for formula I-18, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is Cl, R₈ is CN, R₂ and R₇ are H; R₃, R₄, R₅, R₁₀, n and Q in Table 140 are the same as that of Table 2.

Table 141: Wherein for formula I-18, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N. G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is H, R₈ is CF₃, R₂ and R₇ are H; R₃, R₄, R₅, R₁₀, n and Q in Table 141 are the same as that of Table 2.

Table 142: Wherein for formula I-18, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is H, R₂ is CH₃, R₇ is Cl, R₈ is CN; R₃, R₄, R₅, R₁₀, n and Q in Table 142 are the same as that of Table 2.

Table 143: Wherein for formula I-18, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is CN, R₂ is CH₃, R₇ is CH₃, R₈ is H; R₃, R₄, R₅, R₁₀, n and Q in Table 143 are the same as that of Table 2.

Table 144: Wherein for formula I-18, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is C₁, R₂ is H, R₇ and R₈ are Cl; R₃, R₄, R₅, R₁₀, n and Q in Table 144 are the same as that of Table 2.

Table 145: Wherein for formula I-18, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is C₁, R₂ is CH₃, R₇ is H; R₁, R₄, R₅, R₁₀, n and Q in Table 145 are the same as that of Table 2.

Table 146: Wherein for formula I-18, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CF₃, R₇ is CH(CH₃)₂O; R₃, R₄, R₅, R₁₀, n and Q in Table 146 are the same as that of Table 2.

Table 147: Wherein for formula I-18, NR₄₀—CO-Q is at the 2-position or benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CF₃, R₇ is cyclopropyl; R₃, R₄, R₅, R₁₀, n and Q in Table 147 are the same as that of Table 2.

Table 148: Wherein for formula I-18, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is CH₃, R₂ is Ph, R₇ is CH₃; R₃, R₄, R₅, R₁₀, n and Q in Table 148 are the same as that of Table 2.

Table 149: Wherein for formula I-18, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is CH₃, R₂ is 4-Cl-Ph, R₇ is CH₃; R₃, R₄, R₅, R₁₀, n and Q in Table 149 are the same as that of Table 2.

Table 150: Wherein for formula I-18, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is CH₃, R₂ is 4-CH₃O-Ph, R₇ is CH₃; R₃, R₄, R₅, R₁₀, n and Q in Table 150 are the same as that of Table 2.

Table 151: Wherein for formula I-18, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁, and R₇ are H, R₂ is Cl; R₃, R₄, R₅, R₁₀, n and Q in Table 151 are the same as that of Table 2.

Table 152: Wherein for formula I-18, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is F, R₂ is C₁, R₇ is H; R₃, R₄, R₅, R₁₀, n and Q in Table 152 are the same as that of Table 2.

Table 153: Wherein for formula I-18, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CH₃, R₇ is CH₃O; R₃, R₄, R₅, R₁₀, n and Q in Table 153 are the same as that of Table 2.

Table 154: Wherein for formula I-18, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CH₃, R₇ is (C₂H₅)₂N; R₃, R₄, R₅, R₁₀, n and Q in Table 154 are the same as that of Table 2.

Table 155: Wherein for formula I-18, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CF₃, R₇ is CH₃O; R₃, R₄, R₅, R₁₀, n and Q in Table 155 are the same as that of Table 2.

Table 156: Wherein for formula I-18, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CF₃, R₇ is (C₂H₅)₂N; R₃, R₄, R₅, R₁₀, n and Q in Table 156 are the same as that of Table 2.

Table 157: Wherein for formula I-18, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CH₃, R₇ is CH₃CH₂CH₂; R₃, R₄, R₅, R₁₀, n and Q in Table 157 are the same as that of Table 2.

Table 158: Wherein for formula I-18, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is C₄H₉, R₂ is CH₃, R₇ is (C₂H₅)₂N; R₃, R₄, R₅, R₁₀, n and Q in Table 158 are the same as that of Table 2.

Table 159: Wherein for formula I-18, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is C₄H₉, R₂ is CH₃, R₇ is C₂H₅NH; R₃, R₄, R₅, R₁₀, n and Q in Table 159 are the same as that of Table 2.

Table 160: Wherein for formula I-18, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CH₃, R₇ is Ph-NH; R₃, R₄, R₅, R₁₀, n and Q in Table 160 are the same as that of Table 2.

Table 161: Wherein for formula I-18, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₇ is CF₃, R₇ is 4-Cl-Ph-NH; R₃, R₄, R₅, R₁₀, n and Q in Table 161 are the same as that of Table 2.

Table 162: Wherein for formula I-18, NR₁₀—CO-Q is at the 2-position of benzene ring, G and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CF₃, R₇ is Ph-NH; R₃, R₄, R₅, R₁₀, n and Q in Table 162 are the same as that of Table 2.

Table 163: Wherein for formula I-18, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is 14, R₂ is CH₃, R₇ is 4-Cl-Ph-NH; R₃, R₄, R₅, R₁₀, n and Q in Table 163 are the same as that of Table 2.

Table 164: Wherein for formula I-18, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₂ are N, G₃ is CR₈, X═(CHR₅)_(n), R₁ and R₂ are H, R₈ is Cl; R₃, R₄, R₅, R₁₀, n and Q in Table 164 are the same as that of Table 2.

Table 165: Wherein for formula I-18, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₂ are N, G₃ is CR₈, X═(CHR₅)_(n), R₁, R₂ and R₈ are H; R₃, R₄, R₅, R₁₀, n and Q in Table 165 are the same as that of Table 2.

Table 166: Wherein for formula I-18, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₂ are N, G₃ is CR₈, X═(CHR₅)_(n), R₁ and R₂ are H, R₈ is Ph; R₃, R₄, R₅, R₁₀, n and Q in Table 166 are the same as that of Table 2.

Table 167: Wherein for formula I-18, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁, R₆, R₇ and R₈ are H, R₂ is C(CH₃)₃; R₃, R₄, R₅, R₁₀, n and Q in Table 167 are the same as that of Table 2.

Table 168: Wherein for formula I-18, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂ and R₇ are H, R₁ and R₈ are Cl; R₃, R₄, R₅, R₁₀, n and Q in Table 168 are the same as that of Table 2.

Table 169: Wherein for formula I-18, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂ and R₇ are H, R₁, is Cl, R₈ is CH₃; R₃, R₄, R₅, R₁₀, n and Q in Table 169 are the same as that of Table 2.

Table 170: Wherein for formula I-19, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁, R₂, R₆ and R₇ are H, R₈ is Cl; R₃, R₄, R₅, R₁₀, n and Q in Table 170 are the same as that of Table 2.

Table 171: Wherein for formula I-19, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is CR₆; G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁, R₂, R₆ and R₇ are H, R₈ is CN; R₃, R₄, R₅, R₁₀, n and Q in Table 171 are the same as that of Table 2.

Table 172: Wherein for formula I-19, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁, R₂, R₆ and R₇ are H, R₈ is CF₃; R₃, R₄, R₅, R₁₀, n and Q in Table 172 are the same as that of Table 2.

Table 173: Wherein for formula I-19, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂, R₆ and R₇ are H, R₁ is Cl, R₈ is CF₃; R₃, R₄, R₅, R₁₀, n and Q in Table 173 are the same as that of Table 2.

Table 174: Wherein for formula I-19, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂, R₆ and R₇ are H, R₁ is NO₂, R₈ is CF₃; R₃, R₄, R₅, R₁₀, n and

Q in Table 174 are the same as that of Table 2.

Table 175: Wherein for formula I-19, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂ and R₇ are H, R₁, and R₆ are Cl, R₈ is CF₃; R₃, R₄, R₅, R₁₀, n and Q in Table 175 are the same as that of Table 2.

Table 176: Wherein for formula I-19, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂ and R₇ are H, R₁, and R₆ are NO₂, R₈ is CF₃; R₃, R₄, R₅, R₁₀, n and Q in Table 176 are the same as that of Table 2.

Table 177: Wherein for formula I-19, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂ and R₇ are H, R₁, and R₆ are Cl, R₈ is CN; R₃, R₁, R₅, R₁₀, and Q in Table 177 are the same as that of Table 2.

Table 178: Wherein for formula I-19, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁, and R₆ are NO₂, R₂ is C₁, R₇ is H, R₈ is CF₃; R₃, R₄, R₅, R₁₀, n and Q in Table 178 are the same as that of Table 2.

Table 179: Wherein for formula I-19, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is C₁, R₂, R₇ and R₈ are H; R₃, R₄, R₅, R₁₀; n and Q in Table 179 are the same as that of Table 2.

Table 180: Wherein for formula I-19, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₈ is R₃, R₄, R₂ and R₇ are H; R₃, R₄, R₅, R₁₀, n and Q in Table 180 are the same as that of Table 2.

Table 181: Wherein for formula I-19, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is Cl, R₈ is CF₃, R₂ and R₇ are H; R₃, R₄, R₅, R₁₀, n and Q in Table 181 are the same as that of Table 2.

Table 182: Wherein for formula I-19, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is Cl, R₈ is CN, R₂ and R₇ are H; R₃, R₄, R₅, R₁₀, n and Q in Table 182 are the same as that of Table 2.

Table 183: Wherein for formula I-19, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is H, R₂ is CF₃, R₇ is Cl, R₈ is CN; R₃, R₄, R₅, R₁₀, n and Q in Table 183 are the same as that of Table 2.

Table 184: Wherein for formula I-19, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is H, R₂ is CH₃, R₇ is Cl, R₈ is CN; R₃, R₄, R₅, R₁₀, n and Q in Table 184 are the same as that of Table 2.

Table 185: Wherein for formula I-19, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is CN, R₂ is CH₃, R₇ is CH₃, R₈ is H; R₃, R₄, R₅, R₁₀, n and Q in Table 185 are the same as that of Table 2.

Table 186: Wherein for formula I-19, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is C₁, R₂ is H, R₇ and R₈ are Cl; R₃, R₄, R₅, R₁₀, n and Q in Table 186 are the same as that of Table 2.

Table 187: Wherein for formula I-19, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is C₁, R₂ is CH₃, R₇ is H; R₃, R₄, R₅, R₁₀, n and Q in Table 187 are the same as that of Table 2.

Table 188: Wherein for formula I-19, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CF₃, R₇ is CH(CH₃)₂O; R₃, R₄, R₅, R₁₀, n and Q in Table 188 are the same as that of Table 2.

Table 189: Wherein for formula I-19, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CF₃, R₇ is Cyclopropyl; R₃, R₄, R₅, R₁₀, n and Q in Table 189 are the same as that of Table 2.

Table 190: Wherein for formula I-19, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is CH₃, R₂ is Ph, R₇ is CH₃; R₃, R₄, R₅, R₁₀, n and Q in Table 190 are the same as that of Table 2.

Table 191: Wherein for formula I-19, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is CH₃, R₂ is 4-Cl-Ph, R₇ is CH₃; R₃, R₄, R₅, R₁₀, n and Q in Table 191 are the same as that of Table 2.

Table 192: Wherein for formula I-19, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is CH₃, R₂ is 4-CH₃O-Ph, R₇ is CH₃; R₃, R₄, R₅, R₁₀, n and Q in Table 192 are the same as that of Table 2.

Table 193: Wherein for formula I-19, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ and R₇ are 1-1, R₂ is Cl; R₃, R₄, R₅, R₁₀, n and Q in Table 193 are the same as that of Table 2.

Table 194: Wherein for formula I-19, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is F, R₂ is C₁, R₇ is H; R₃, R₄, R₅, R₁₀, n and Q in Table 194 are the same as that of Table 2.

Table 195: Wherein for formula I-19, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CH₃, R₇ is CH₃O; R₃, R₄, R₅, R₁₀, n and Q in Table 195 are the same as that of Table 2.

Table 196: Wherein for formula I-19, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅), R₁ is H, R₂ is CH₃, R₇ is (C₂H₅)₂N; R₃, R₄, R₅, R₁₀, n and Q in Table 196 are the same as that of Table 2.

Table 197: Wherein for formula I-19, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CF₃, R₇ is CH₃O; R₃, R₄, R₅, R₁₀, n and Q in Table 197 are the same as that of Table 2.

Table 198: Wherein for formula I-19, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CF₃, R₇ is (C₂H₅)₂N; R₃, R₄, R₅, R₁₀, n and Q in Table 198 are the same as that of Table 2.

Table 199: Wherein for formula I-19, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CH₃, R₇ is CH₃CH₂CH₂; R₃, R₄, R₅, R₁₀, n and Q in Table 199 are the same as that of Table 2.

Table 200: Wherein for formula I-19, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is C₄H₉, R₂ is CH₃, R₇ is (C₂H₅)₂N; R₃, R₄, R₅, R₁₀, n and Q in Table 200 are the same as that of Table 2.

Table 201: Wherein for formula I-19, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is C₄H₉, R₂ is CH₃, R₇ is C₂H₅NH; R₃, R₄, R₅, R₁₀, n and Q in Table 201 are the same as that of Table 2.

Table 202: Wherein for formula I-19, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CH₃, R₇ is Ph-NH, R₃; R₄, R₅, R₁₀, n and Q in Table 202 are the same as that of Table 2.

Table 203: Wherein for formula I-19, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CF₃, R₇ is 4-Cl-Ph-NH; R₃, R₄, R₅, R₁₀, n and Q in Table 203 are the same as that of Table 2.

Table 204: Wherein for formula I-19, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is R₇ is Ph-NH; R₃, R₄, R₅, R₁₀, n and Q in Table 204 are the same as that of Table 2.

Table 205: Wherein for formula I-19, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CH₃, R₇ is 4-Cl-Ph-NH; R₃, R₄, R₅, R₁₀, n and Q in Table 205 are the same as that of Table 2.

Table 206: Wherein for formula I-19, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₂ are N, G₃ is CR₈, X═(CHR₅)_(n), R₁ and R₂ are H, R₈ is Cl; R₃, R₄, R₅, R₁₀, n and Q in Table 206 are the same as that of Table 2.

Table 207: Wherein for formula I-19, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₂ are N, G₃ is CR₈, X═(CHR₅)_(n), R₁, R₂ and R₈ are 11; R₃, R₄, R₅, R₁₀, n and Q in Table 207 are the same as that of Table 2.

Table 208: Wherein for formula I-19, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₂ are N, G₃ is CR₈, X═(CHR₅)_(n), R₁ and R₂ are H, R₈ is Ph; R₃, R₄, R₅, R₁₀, n and Q in Table 208 are the same as that of Table 2.

Table 209: Wherein for formula I-19, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁, R₆, R₇ and R₈ are H, R₂ is C(CH₃)₃; R₃, R₄, R₅, R₁₀, n and Q in Table 209 are the same as that of Table 2.

Table 210: Wherein for formula I-19, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂ and R₇ are Ft, R₁ is Cl, R₈ is CH₃; R₃, R₄, R₅, R₁₀, n and Q in Table 210 are the same as that of Table 2.

Table 211: Wherein for formula I-19, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂ and R₇ are H, R₁ and R₃ are Cl; R₃, R₄, R₅, R₁₀, n and Q in Table 211 are the same as that of Table 2.

Table 212: Wherein for formula I-22, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁, R₂, R₆ and R₇ are H, R₈ is Cl; R₃, R₄, R₅, R₁₀, n and Q in Table 212 are the same as that of Table 2.

Table 213: Wherein for formula I-22, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁, R₂, R₆ and R₇ are H, R₈ is CN; R₃, R₄, R₅, R₁₀, n and Q in Table 213 are the same as that of Table 2.

Table 214: Wherein for formula I-22, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is CR₆, is G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁, R₂, R₆ and R₇ are H, R₈ is CF₃; R₃, R₄, R₅, R₁₀, n and Q in Table 214 are the same as that of Table 2.

Table 215: Wherein for formula I-22, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₇, R₆ and R₇ are H, R₁ is Cl, R₈ is CF₃; R₃, R₄, R₅, R₁₀, n and Q in Table 215 are the same as that of Table 2.

Table 216: Wherein for formula I-22, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂, R₆ and R₇ are H, R₁ is NO₂, R₈ is CF₃; R₃, R₄, R₅, R₁₀, n and Q in Table 216 are the same as that of Table 2.

Table 217: Wherein for formula I-22, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂ and R₇ are H, R₁ and R₆ are Cl, R₈ is CF₃; R₃, R₄, R₅, R₁₀, n and Q in Table 217 are the same as that of Table 2.

Table 218: Wherein for formula I-22, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂ and R₇ are 14, R₁ and R₆ are NO₂, R₈ is CF₃; R₃, R₄, R₅, R₁₀, n and Q in Table 218 are the same as that of Table 2.

Table 219: Wherein for formula I-22, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂ and R₇ are H, R₁ and R₆ are Cl, R₈ is CN; R₃, R₄, R₅, R₁₀, n and Q in Table 219 are the same as that of Table 2.

Table 220: Wherein for formula I-22, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ and R₆ are NO₂, R₂ is C₁, R₇ is H, R₈ is CF₃; R₃, R₄, R₅, R₁₀, n and Q in Table 220 are the same as that of Table 2.

Table 221: Wherein for formula I-22, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is C₁, R₂, R₇ and R₈ are 11; R₃, R₄, R₅, R₁₀, n and Q in Table 221 are the same as that of Table 2.

Table 222: Wherein for formula I-22, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₈ is CF₃, R₄, R₂ and R₇ are H; R₃, R₄, R₅, R₁₀, n and Q in Table 222 are the same as that of Table 2.

Table 223: Wherein for formula I-22, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is Cl, R₈ is CF₃, R₁, R₂ and R₇ are H; R₃, R₄, R₅, R₁₀, n and Q in Table 223 are the same as that of Table 2.

Table 224: Wherein for formula I-22, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is Cl, R₈ is CN, R₂ and R₇ are H; R₃, R₄, R₅, R₁₀, n and Q in Table 224 are the same as that of Table 2.

Table 225: Wherein for formula I-22, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is H, R₂ is CF₃, R₇ is Cl, R₈ is CN; R₃, R₄, R₅, R₁₀, n and Q in Table 225 are the same as that of Table 2.

Table 226: Wherein for formula I-22, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is H, R₂ is CH₃, R₇ is Cl, R₈ is CN; R₃, R₄, R₅, R₁₀, n and Q in Table 226 are the same as that of Table 2.

Table 227: Wherein for formula I-22, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is CN, R₂ is CH₃, R₇ is CH₃, R₈ is 14; R₃, R₄, R₅, R₁₀, n and Q in Table 227 are the same as that of Table 2.

Table 228: Wherein for formula I-22, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is C₁, R₂ is H, R₇ and R₈ are Cl; R₃, R₄, R₅, R₁₀, n and Q in Table 228 are the same as that of Table 2.

Table 229: Wherein for formula I-22, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is C₁, R₂ is CH₃, R₇ is H; R₃, R₄, R₅, R₁₀, n and Q in Table 229 are the same as that of Table 2.

Table 230: Wherein for formula I-22, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CF₃, R₇ is CH(CH₃)₂O; R₃, R₄, R₅, R₁₀, n and Q in Table 230 are the same as that of Table 2.

Table 231: Wherein for formula I-22, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CF₃, R₇ is cyclopropyl; R₃, R₄, R₅, R₁₀, n and Q in Table 231 are the same as that of Table 2.

Table 232: Wherein for formula I-22, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is CH₃, R₂ is Ph, R₇ is CH₃; R₃, R₄, R₅, R₁₀, n and Q in Table 232 are the same as that of Table 2.

Table 233: Wherein for formula I-22, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is CH₃, R₂ is 4-Cl-Ph, R₇ is CH₃; R₃, R₄, R₅, R₁₀, n and Q in Table 233 are the same as that of Table 2.

Table 234: Wherein for formula I-22, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is CH₃, R₂ is 4-CH₃O-Ph, R₇ is CH₃; R₃, R₄, R₅, R₁₀, n and Q in Table 234 are the same as that of Table 2.

Table 235: Wherein for formula I-22, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ and R₇ are H, R₂ is Cl; R₃, R₄, R₅, R₁₀, n and Q in Table 235 are the same as that of Table 2.

Table 236: Wherein for formula I-22, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is F, R₂ is C₁, R₇ is H; R₃, R₄, R₅, R₁₀, n and Q in Table 236 are the same as that of Table 2.

Table 237: Wherein for formula I-22, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CH₃, R₇ is CH₃O; R₃, R₄, R₅, R₁₀, n and Q in Table 237 are the same as that of Table 2.

Table 238: Wherein for formula I-22, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CH₃, R₇ is (C₂H₅)₂N; R₃, R₄, R₅, R₁₀, n and Q in Table 238 are the same as that of Table 2.

Table 239: Wherein for formula I-22, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CF₃, R₇ is CH₃O; R₁, R₄, R₅, R₁₀, n and Q in Table 239 are the same as that of Table 2.

Table 240: Wherein for formula I-22, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CF₃, R₇ is (C₂H₅)₂N; R₃, R₄, R₅, R₁₀, n and Q in Table 240 are the same as that of Table 2.

Table 241: Wherein for formula I-22, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CH₃, R₇ is CH₃CH₂CH₂; R₃, R₄, R₅, R₁₀, n and Q in Table 241 are the same as that of Table 2.

Table 242: Wherein for formula I-22, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is C₄H_(Y), R₂ is CH₃, R₇ is (C₂H₅)₂N; R₃, R₄, R₅, R₁₀, n and Q in Table 242 are the same as that of Table 2.

Table 243: Wherein for formula I-22, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is C₄H₉, R₂ is CH₃, R₇ is C₂H₅NH; R₃, R₄, R₅, R₁₀, n and Q in Table 243 are the same as that of Table 2.

Table 244: Wherein for formula I-22, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CH₃, R₇ is Ph-NH; R₃, R₄, R₅, R₁₀, n and Q in Table 244 are the same as that of Table 2.

Table 245: Wherein for formula I-22, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CF₃, R₇ is 4-Cl-Ph-NH; R₃, R₄, R₅, R₁₀, n and Q in Table 245 are the same as that of Table 2.

Table 246: Wherein for formula I-22, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CF₃, R₇ is Ph-NH; R₃, R₄, R₅, R₁₀, n and Q in Table 246 are the same as that of Table 2.

Table 247: Wherein for formula I-22, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CH₃, R₇ is 4-Cl-Ph-NH; R₃, R₄, R₅, R₁₀, n and Q in Table 247 are the same as that of Table 2.

Table 248: Wherein for formula I-22, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₂ are N, G₃ is CR₈, X═(CHR₅)_(n), R₁ and R₂, are H, R₈ is Cl; R₃, R₄, R₅, R₁₀, n and Q in Table 248 are the same as that of Table 2.

Table 249: Wherein for formula I-22, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₂ are N, G₃ is CR₈, X═(CHR₅)_(n), R₁, R₂ and R₈ are H; R₃, R₄, R₅, R₁₀, n and Q in Table 249 are the same as that of Table 2.

Table 250: Wherein for formula I-22, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₂ are N, G₃ is CR₈, X═(CHR₅)_(n), R₁ and R₂ are H, R₈ is Ph; R₃, R₄, R₅, R₁₀, n and Q in Table 250 are the same as that of Table 2.

Table 251: Wherein for formula I-22, NR₁₆—CO-Q is at the 2-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁, R₆, R₇ and R₈ are H, R₂ is C(CH₃)₃; R₃, R₄, R₅, R₁₀, n and Q in Table 251 are the same as that of Table 2.

Table 252: Wherein for formula I-22, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂ and R₇ are H, R₁ is Cl, R₈ is CH₃; R₃, R₄, R₅, R₁₀, n and Q in Table 252 are the same as that of Table 2.

Table 253: Wherein for formula I-22, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂ and R₇ are H, R₁ and R₈ are Cl; R₃, R₄, R₅, R₁₀, n and Q in Table 253 are the same as that of Table 2.

Table 254: Wherein for formula I-26, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁, R₂, R₆ and R₇ are H, R₈ is Cl; R₃, R₄, R₅, R₁₀, n and Q in Table 254 are the same as that of Table 2.

Table 255: Wherein for formula I-26, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁, R₂, R₆ and R₇ are H, R₈ is CN; R₃, R₄, R₅, R₁₀, n and Q in Table 255 are the same as that of Table 2.

Table 256: Wherein for formula I-26, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁, R₂, R₆ and R₇ are H, R₈ is CF₃; R₃, R₄, R₅, R₁₀, n and Q in Table 256 are the same as that of Table 2.

Table 257: Wherein for formula I-26, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂, R₆ and R₇ are H, R₁ is Cl, R₈ is CF₃; R₃, R₄, R₅, R₁₀, n and Q in Table 257 are the same as that of Table 2.

Table 258: Wherein for formula I-26, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂, R₆ and R₇ are H, R₁ is NO₂, R₈ is CF₃; R₃, R₄, R₅, R₁₀, n and Q in Table 258 are the same as that of Table 2.

Table 259: Wherein for formula I-26, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is CR₆, 07 is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R) and R₇ are 1-1, R₁ and R₆ are Cl, R₈ is CF₃; R₃, R₄, R₅, R₁₀, n and Q in Table 259 are the same as that of Table 2.

Table 260: Wherein for formula I-26, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is CR₆, 07 is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂ and R₇ are H, R₁ and R₆ are NO₂, R₈ is CF₃; R₃, R₄, R₅, R₁₀, n and Q in Table 260 are the same as that of Table 2.

Table 261: Wherein for formula I-26, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂ and R₇ are H, R₁ and R₆ are Cl, R₈ is CN; R₃, R₄, R₅, R₁₀, n and Q in Table 261 are the same as that of Table 2.

Table 262: Wherein for formula I-26, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is CR₆, 07 is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ and R₆ are NO₂, R₂ is C₁, R₇ is H, R₈ is CF₃; R₃, R₄, R₅, R₁₀, n and Q in Table 262 are the same as that of Table 2.

Table 263: Wherein for formula I-26, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is C₁, R₂, R₇ and R₈ are H, R₇ is H; R₃, R₄, R₅, R₁₀, n and Q in Table 263 are the same as that of Table 2.

Table 264: Wherein for formula I-26, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₈ is CF₃, R₄, R₂ and R₇ are H; R₃, R₄, R₅, R₁₀, n and Q in Table 264 are the same as that of Table 2.

Table 265: Wherein for formula I-26, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is Cl, R₈ is CF₃, R₂ and R₇ are H; R₃, R₄, R₅, R₁₀, n and Q in Table 265 are the same as that of Table 2.

Table 266: Wherein for formula I-26, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is Cl, R₈ is CN, R₂ and R₇ are H; R₃, R₄, R₅, R₁₀, n and Q in Table 266 are the same as that of Table 2.

Table 267: Wherein for formula I-26, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is 14, R₂ is CF₃, R₇ is Cl, R₈ is CN; R₃, R₄, R₅, R₁₀, n and Q in Table 267 are the same as that of Table 2.

Table 268: Wherein for formula I-26, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁, is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is H, R₂ is CH₃, R₇ is Cl, R₈ is CN; R₃, R₄, R₅, R₁₀, n and Q in Table 268 are the same as that of Table 2.

Table 269: Wherein for formula I-26, NR₁₀—CO-Q is at the 2-position of benzene ring, G₂ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is CN, R₂ is CH₃, R₇ is CH₃, R₈ is H; R₃, R₄, R₅, n and Q in Table 269 are the same as that of Table 2.

Table 270: Wherein for formula I-26, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁ is C₁, R₂ is H, R₇ and R₈ are Cl; R₃, R₄, R₅, R₁₀, n and Q in Table 270 are the same as that of Table 2.

Table 271: Wherein for formula I-26, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is C₁, R₂ is CH₃, R₇ is Cl; R₃, R₄, R₅, R₁₀, n and Q in Table 271 are the same as that of Table 2.

Table 272: Wherein for formula I-26, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CF₃, R₇ is CH(CH₃)₂O; R₃, R₄, R₅, R₁₀, n and Q in Table 272 are the same as that of Table 2.

Table 273: Wherein for formula I-26, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CF₃, R₇ is cyclopropyl; R₃, R₄, R₅, R₁₀, n and Q in Table 273 are the same as that of Table 2.

Table 274: Wherein for formula I-26, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is CH₃, R₂ is Ph, R₇ is CH₃; R₃, R₄, R₅, R₁₀, n and Q in Table 274 are the same as that of Table 2.

Table 275: Wherein for formula I-26, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is CH₃, R₂ is 4-Cl-Ph, R₇ is CH₃; R₃, R₄, R₅, R₁₀, n and Q in Table 275 are the same as that of Table 2.

Table 276: Wherein for formula I-26, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is CH₃, R₂ is 4-CH₃O-Ph, R₇ is CH₃; R₃, R₄, R₅, R₁₀, n and Q in Table 276 are the same as that of Table 2.

Table 277: Wherein for formula I-26, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ and R₇ are H, R₂ is Cl; R₃, R₄, R₅, R₁₀, n and Q in Table 277 are the same as that of Table 2.

Table 278: Wherein for formula I-26, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is F, R₂ is C₁, R₇ is H; R₃, R₄, R₅, R₁₀, n and Q in Table 278 are the same as that of Table 2.

Table 279: Wherein for formula I-26, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CH₃, R₇ is CH₃O; R₃, R₄, R₅, R₁₀, n and Q in Table 279 are the same as that of Table 2.

Table 280: Wherein for formula I-26, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is F₁, R₂ is CH₃, R₇ is (C₂H₅)₂N; R₃, R₄, R₅, R₁₀, n and Q in Table 280 are the same as that of Table 2.

Table 281: Wherein for formula I-26, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CF₃, R₇ is CH₃O; R₃, R₄, R₅, R₁₀, n and Q in Table 281 are the same as that of Table 2.

Table 282: Wherein for formula I-26, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R—) is CH₃, R₇ is (C₂H₅)₂N; R₃, R₄, R₅, R₁₀, n and Q in Table 282 are the same as that of Table 2.

Table 283: Wherein for formula I-26, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CH₃, R₇ is CH₃CH₂CH₂; R₃, R₄, R₅, R₁₀, n and Q in Table 283 are the same as that of Table 2.

Table 284: Wherein for formula I-26, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is C₄H₉, R₂ is CH₃, R₇ is (C₂H₅)₂N; R₃, R₄, R₅, R₁₀, n and Q in Table 284 are the same as that of Table 2.

Table 285: Wherein for formula I-26, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is C₄H₉, R₂ is CH₃, R₇ is C₂H₅NH; R₃, R₄, R₅, R₁₀, n and Q in Table 285 are the same as that of Table 2.

Table 286: Wherein for formula I-26, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CH₃, R₇ is Ph-NH; R₃, R₄, R₅, R₁₀, n and Q in Table 286 are the same as that of Table 2.

Table 287: Wherein for formula I-26, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CF₃, R₇ is 4-Cl-Ph-NH; R₃, R₄, R₅, R₁₀, n and Q in Table 287 are the same as that of Table 2.

Table 288: Wherein for formula I-26, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CF₃, R₇ is Ph-NH; R₃, R₄, R₅, R₁₀, n and Q in Table 288 are the same as that of Table 2.

Table 289: Wherein for formula I-26, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₃ are N, G₂ is CR₇, X═(CHR₅)_(n), R₁ is H, R₂ is CH₃, R₇ is 4-Cl-Ph-NH; R₃, R₄, R₅, R₁₀, n and Q in Table 289 are the same as that of Table 2.

Table 290: Wherein for formula I-26, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₂ are N, G₃ is CR₈, X═(CHR₅)₂, R₁ and R₂ are H, R₈ is Cl; R₃, R₄, R₅, R₁₀, n and Q in Table 290 are the same as that of Table 2.

Table 291: Wherein for formula I-26, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₂ are N, G₃ is CR₈, X═(CHR₅)_(n), R₁, R₂ and R₈ are H; R₃, R₄, R₅, R₁₀, n and Q in Table 291 are the same as that of Table 2.

Table 292: Wherein for formula I-26, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ and G₂ are N, G₃ is CR₈, X═(CHR₅)_(n), R₁ and R₂ are H, R₈ is Ph; R₃, R₄, R₅, R₁₀, n and Q in Table 292 are the same as that of Table 2.

Table 293: Wherein for formula I-26, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is CR₆, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₁, R₆, R₇ and R₈ are H, R₂ is C(CH₃)₃; R₃, R₄, R₅, R₁₀, n and Q in Table 293 are the same as that of Table 2.

Table 294: Wherein for formula I-26, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂ and R₇ are H, R₁ is Cl, R₈ is CH₃; R₃, R₄, R₅, R₁₀, n and Q in Table 294 are the same as that of Table 2.

Table 295: Wherein for formula I-26, NR₁₀—CO-Q is at the 2-position of benzene ring, G₁ is N, G₂ is CR₇, G₃ is CR₈, X═(CHR₅)_(n), R₂ and R₇ are H, R₁ and R₈ are Cl; R₃, R₄, R₅, R₁₀, n and Q in Table 295 are the same as that of Table 2.

The present invention also relates to a preparation method of the compounds represented by the formula I, which can be prepared by reaction of the compounds containing amine group of the general formula IV with substituted benzoxazinone of the general formula V-A or aromatic acid chloride of the general formula V-B at the present of base:

Wherein:

L is leaving group, such as Cl or Br, other groups are as defined above.

When R₁₀ is H and NR₁₀—CO-Q is at the 2-position of benzene ring, the compounds of the general formula I can be prepared by reacting (un)substituted amines of the general formula IV with substituted benzoxazinone of the general formula V-A.

When R₁₀ is not H, and NR₁₀—CO-Q is at the 2-position of benzene ring or not, the compounds of the general formula I can be prepared by reacting (un)substituted amine compounds of the general formula IV with aromatic acid chloride of the general formula V-B at the present of base.

L is leaving group in general formula, such as Cl or Br, other groups are as defined above.

The general formula IV as intermediates in above reaction can be prepared by reacting aromatic halide or sulphonic acid ester compounds of the general formula II with the disubstituted or unsubstituted amine compounds of the general formula III.

In general formula II, R is leaving group, such as Cl, Br, OSO₂CH₃ or OSO₂Ph: other groups are as defined above.

The two reactions mentioned above are similar, including react in solvent, the proper solvent may be selected from tetrahydrofuran, acetonitrile, toluene, xylene, benzene, DMF, DMSO, acetone or butanone and so on.

The proper base mentioned above may be selected from potassium hydroxide, sodium hydroxide, sodium carbonate, potassium carbonate, sodium bicarbonate, triethylamine, pyridine, sodium methoxide, sodium ethoxide, sodium hydride, potassium or sodium tert-butoxide and so on.

The proper temperature mentioned above is from room temperature to boiling point of solvent, normally the temperature is at 15 to 100° C.

The reaction may be last for 15 minutes to 20 hours, usually for 0.5 hour to 10 hours.

Aromatic halide compounds represented by the general formula II and disubstituted or unsubstituted amine compounds represented by the general formula III can be bought or prepared by conventional methods; sulphonic acid ester compounds of the general formula II can be prepared according to known methods, refer to JP56029504; benzoxazinone compounds of the general formula V-A can be prepared according to known methods, refer to WO03015519.

The general formula V-B as intermediates can be prepared from substituted amino methyl or ethyl benzoate (bought or prepared by conventional methods) by conventional methods; including amidation, alkylation, hydrolysis, chloroformylation and so on. The reaction as follows:

The compounds having formula I in present invention are obvious different in structures from known piperazine and amide compounds. The compounds having general formula I in the present invention have a high insecticidal activity which is exerted with respect to the adults, larvae and eggs of insects which are harmful in the agricultural, civil and zoo-technical field, the compounds disclosed in the present invention also exhibit preferably fungicidal activity. A further object of the present invention therefore relates to the use of the compounds having general formula I as insecticides and/or fungicides, both in agriculture and other fields.

In particular, the compounds having general formula I are active against important species of lepidopteran, including european corn borer, sugarcane borer, codlingmoth, codling moth, gypsymoth, rice leafroller, corn borer, tobacco budworm, fruit moth, diamond back moth, cotton leafworm, especially showed good control of diamond back moth and cotton leafworm at very low doses. Additionally, some compounds in present invention also exhibit excellent fungicidal activity, which can be used to control of rice blast, tomato late blight, cucumber downy mildew, cucumber anthracnose, corn rust, wheat powdery mildew etc.

A further object of the present invention relates to insecticidal and fungicidal compositions containing compounds having general formula I as active principle and acceptable carrier in agriculture, the active component of the compositions in the weight ratio of 0.1-99%.

Compounds of the invention will generally be used as a formulation or composition with an agriculturally suitable carrier comprising at least one of a liquid diluent, a solid diluent or a surfactant. The formulation or composition ingredients are selected to be consistent with the physical properties of the active ingredient, mode of application and environmental factors such as soil type, moisture and temperature. Useful formulations include liquids such as solutions (including emulsifiable concentrates), suspensions, emulsions (including microemulsions and/or suspoemulsions) and the like which optionally can be thickened into gels. Useful formulations further include solids such as dusts, powders, granules, pellets, tablets, films, and the like which can be water-dispersible (“wettable”) or water-soluble. Active ingredient can be (micro)encapsulated and further formed into a suspension or solid formulation; alternatively the entire formulation of active ingredient can be encapsulated (or “overcoated”). Encapsulation can control or delay release of the active ingredient. Sprayable formulations can be extended in suitable media and used at spray volumes from about one to several hundred liters per hectare. High-strength compositions are primarily used as intermediates for further formulation.

The formulations will typically contain effective amounts of active ingredient, diluent and surfactant within the following approximate ranges that add up to 100 percent by weight

Weight Percent Active Ingredient Diluent Surfactant Water-Dispersible and Water-soluble, 5-90 0-94 1-15 Granules, Tablets and Powders. Suspensions, Emulsions, Solutions 5-50 40-95  0-15 (including Emulsifiable Concentrates) Granules or Pellets 0.01-99     5-99.99 0-15 High Strength Compositions 90-99  0-10 0-2 

Typical solid diluents are described by Watkins, et al., in Handbook of Insecticide Dust Diluents and Carriers, 2nd Ed., Dorland Books, Caldwell, N.J. Typical liquid diluents are described by Marsden. Solvents Guide, 2nd Ed., Interscience, New York, 1950. McCutcheora's Detergents and Emulsifiers Annual, Allwed Publ. Corp., Ridgewood, N.J., as well as Sisely and Wood, Encyclopedia of Surface Active Agents, Chemical Publ. Co., Inc., New York, 1964, list surfactants and recommended uses. All formulations can contain minor amounts of additives to reduce foam, caking, corrosion, microbiological growth and the like, or thickeners to increase viscosity.

Surfactants include, for example, polyethoxylated alcohols, polyethoxylated alkylphenols, polyethoxylated sorbitan fatty acid esters, dialkyl sulfosuccinates, alkyl sulfates, alkylbenzene sulfonates, organosilicones, N, N-dialkyltaurates, lignin sulfonates, naphthalene sulfonate formaldehyde condensates, polycarboxylates, and polyoxyethylene/polyoxypropylene block copolymers. Solid diluents include, for example, clays such as bentonite, montmorillonite, attapulgite and kaolin, starch, sugar, silica, talc, diatomaceous earth, urea, calcium carbonate, sodium carbonate and bicarbonate, and sodium sulfate. Liquid diluents include, for example, water, N,N-dimethylformamide, dimethyl sulfoxide, N-alkylpyrrolidone, ethylene glycol, polypropylene glycol, paraffins, alkylbenzenes, alkylnaphthalenes, oils of olive, castor, linseed tung, sesame, corn, peanut, cotton-seed, soybean, rape-seed and coconut, fatty acid esters, ketones such as cyclohexanone, 2-heptanone, isophorone and 4-hydroxy-4-methyl-2-pentanone, and alcohols such as methanol, cyclohexanol, decanol and tetrahydrofurfuryl alcohol.

Formulations can be prepared as following:

Dustable powders (DP) may be prepared by mixing a compound of active ingredient with one or more solid diluents and then mechanically grinding the mixture to a fine powder.

Soluble powders (SP) may be prepared by mixing a compound of active ingredient with one or more water-soluble inorganic salts (such as sodium bicarbonate, sodium carbonate or magnesium sulphate) or one or more water-soluble organic solids (such as a polysaccharide) and, optionally, one or more wetting agents, one or more dispersing agents or a mixture of said agents to improve water dispersibility/solubility. The mixture is then ground to a fine powder. Similar compositions may also be granulated to form water solubleules (SG).

Wettable powders (WP) may be prepared by mixing a compound of formula (I) with one or more solid diluents or carriers, one or more wetting agents and, preferably, one or more dispersing agents and, optionally, one or more suspending agents to facilitate the dispersion in liquids. The mixture is then ground to a fine powder. Similar compositions may also be granulated to form water dispersible granules (WG).

Granules (GR) may be formed either by granulating a mixture of a compound of active ingredient and one or more powdered solid diluents or carriers, or from pre-formed blank granules by absorbing a compound of active ingredient (or a solution thereof, in a suitable agent) in a porous granular material (such as pumice, attapulgite clays, fuller's earth, kieselguhr, diatomaceous earths or ground corn cobs) or by adsorbing a compound of active ingredient (or a solution thereof in a suitable agent) on to a hard core material (such as sands, silicates, mineral carbonates, sulphates or phosphates) and drying if necessary. Agents which are commonly used to aid absorption or adsorption include solvents (such as aliphatic and aromatic petroleum solvents, alcohols, ethers, ketones and esters) and sticking agents (such as polyvinyl acetates, polyvinyl alcohols, dextrins, sugars and vegetable oils). One or more other additives may also be included in granules (for example an emulsifying agent, wetting agent or dispersing agent).

Suspension concentrates (SC) may comprise aqueous or non-aqueous suspensions of finely divided insoluble solid particles of a compound of active ingredient. SC may be prepared by ball or bead milling the solid compound of active ingredient in a suitable medium, optionally with one or more dispersing agents, to produce a fine particle suspension of the compound. One or more wetting agents may be included in the composition and a suspending agent may be included in the composition to reduce the rate at which the particles settle. Alternatively, a compound of formula (I) may be dry milled and then added to water which contains agents hereinbefore described, to produce the desired end product.

The composition to which one or more other insecticides/fungicides are added has wider spectrum activity than single compound having general formula I. In addition, other insecticides/fungicides may have synergistic effect on the insecticidal/fungicidal activity of the compound having general formula I. The compound having general formula I can also be used with other insecticides, or with another fungicide simultaneously.

DESCRIPTION OF THE INVENTION IN DETAIL

The following examples are illustrative to the present invention, but without being restricted thereby.

PREPARATION EXAMPLE Example 1 The preparation of compound 83 in Table 181

(1) The Preparation of Intermediate IV-1

9 g (150 mmol) of 1,2-ethylenediamine and 100 ml, ethanol were added to a 250 mL flask, then 22.7 g (100 mmol) of 2,3-dichloro-5-(trifluoromethyl)pyridine was added dropwise to the solution in 30 min, stirred at room temperature for 2 h. The reaction was monitored by thin-layer chromatography (TLC), upon completion, the solvent was removed under reduced pressure, 22 g light yellow oil was obtained (91.7% yield).

(2) The Preparation of Compound 83 in Table 181

1.00 g (2.21 mmol) of 2-(3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl)-6-chloro-8-methyl-4H-benzo[d][1,3]oxazin-4-one (prepared according to the method disclosed in WO03015519) and 25 mL acetonitrile were added to a 50 mL flask, then 0.53 g (2.21 mmol) of IV-1 was added to the solution and stirred at 40° C. for 4 h. The reaction was monitored by TLC, upon completion, the solvent was removed under reduced pressure, then 50 mL of saturated brine was poured into the flask, extracted with 60 mL ethyl acetate for three times, the combined organic extacts were dired and concentrated. The crude product was purified through silica column (ethyl acetate:petroleum ether=1:3) and 0.65 g of target compound was obtained (42.7% yield).

Example 2 The Preparation of Compound 303 in Table 181

(1) The Preparation of Intermediate IV-2

11.8 g (60 mmol) of piperazine hexahydrate was added to a 150 mL flask with 40 mL acetonitrile, heated to 40° C. 10.8 g (50 mmol) of 2,3-dichloro-5-(trifluoromethyl)pyridine was added dropwise to the solution in 15 min, then 9 mL triethylamine was added to the mixture and stirred at 40° C. for 4 h. The reaction was monitored by TLC, upon completion, filtrated and washed by a little ethanol to obtain 12 g white solid (90.2% yield).

(2) The Preparation of Compound 303 in Table 181

1.00 g (2.21 mmol) of 2-(3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl)-6-chloro-8-methyl-4H-benzo[d][1,3]oxazin-4-one (prepared according to WO03015519) and 25 mL acetonitrile were added to a 50 mL, flask, then 0.59 g (2.21 mmol) of IV-2 was added to the solution and stirred at 40 for 4 h. The reaction was monitored by TLC, upon completion, the solvent was removed under reduced pressure, and then 50 mL saturated brine was poured into the flask, extracted with 60 mL ethyl acetate for three times, the combined organic extacts were dired and concentrated. The crude product was purified through silica column (ethyl acetate:petroleum ether=1:3) and 0.58 g target compound was obtained (38.2% yield).

Example 3 The Preparation of Compound 107 in Table 96

(1) The Preparation of Intermediate V-B1

1.65 g (10 mmol) of methyl 4-amino-3-methylbenzoate and 20 mL THF were added to a 50 mL flask, and then 2.50 g (11 mmol) of acylchloride was added to the above solution and stirred at room temperature for 4 h. The reaction was monitored by TLC, upon completion, the solvent was removed under reduced pressure, then 20 mL saturated brine was poured into the flask, extracted with 60 mL ethyl acetate for three times, the combined organic extacts were washed by saturated sodium carbonate solution, dired to obtain brown solid. Then 0.8 g (20 mmol) of sodium hydroxide, 10 mL water and 20 mL ethanol were added to the flask, stirred at 50° C. for 3 h. The reaction was monitored by TLC, upon completion, the solvent was removed under reduced pressure, then 40 mL water was poured into the flask, extracted with 30 mL ethyl acetate for three times, the water layer were acidified by concentrated hydrochloric acid to weak acidity, filtrated to obtain 2.78 g white solid V-B1 (81.3% yield).

(2) The Preparation of Compound 107 in Table 96

0.34 g (1 mmol) of intermediate V-B1 and 15 mL acetonitrile were added to a 50 mL flask, then 0.24 g (1 mmol) of IV-1 and 0.3 mL pyridine were added to the solution in sequence, cooled to 5° C. or less by ice bath and stirred for 10 min. Then 0.3 mL of methanesulfonyl chloride was added dropwise to the solution, removed ice bath, the reaction mixture stirred overnight at room temperature. The reaction was monitored by TLC, upon completion, the solvent was removed under reduced pressure, then 30 mL saturated brine was poured into the flask, extracted with 60 mL ethyl acetate for three times, the combined organic extacts were washed by saturated sodium carbonate solution for two times, dired and concentrated to obtain light yellow solid. The crude product was washed by a little ether, filtrated to obtain 0.27 g white solid (47.9% yield).

Other compounds of the formula I were prepared according the above examples.

Mp. and ¹H NMR spectrum of some compounds of the formula I are as follows:

Table Compound Mp. (° C.) and ¹HNMR (300 MHz, internal standard: TMS, solvent No. No. CDCl₃) 96 83 m.p. 102-103; δppm 2.40 (3H, s), 3.81 (4H, m), 7.20 (1H, s), 7.38 (3H, m), 7.68 (2H, m), 7.86 (1H, d), 8.28 (1H, s), 8.36 (1H, m). 96 107 m.p. 140-142; δppm 1.34 (6H, s), 2.28 (3H, s), 3.72 (2H, s), 3.78 (2H, s), 6.12 (1H, s), 6.42 (1H, d), 7.14 (1H, s), 7.25 (1H, s), 7.51 (1H, d), 7.58 (1H, s), 7.64 (1H, s), 7.96 (1H, s), 8.26 (1H, s). 96 303 m.p. 158-160; δppm 2.45 (3H, s), 3.56 (4H, m), 3.94 (4H, m), 5.22 (1H, s), 7.31 (3H, m), 7.44 (1H, s), 7.81 (1H, d), 7.87 (1H, d), 8.42 (2H, m). 96 327 m.p. 98-99; δppm 1.28 (2H, m), 1.33 (6H, s), 2.26 (3H, s), 3.52 (8H, m), 6.41 (1H, s), 7.25 (3H, m), 7.79 (2H, m), 8.41 (1H, s). 126 107 m.p. 103-105; δppm 1.24 (2H, m), 1.29 (6H, m), 3.00 (3H, s), 3.68 (4H, s), 5.62 (1H, m), 7.37 (1H, s), 7.48 (2H, m), 7.60 (1H, s), 7.97 (1H, m). 139 83 δppm 2.27 ((3H, s), 3.30 (2H, m), 3.47 (2H, m), 7.19 (1H, s), 7.67 (1H, s), 7.89 (1H, s), 8.21 (1H, s). 139 199 δppm 1.89 (m, 2H), 2.26 (s, 3H), 3.49 (q, 2H), 3.68 (q, 2H), 5.82 (s, 1H), 7.06 (s, 1H), 7.39 (q, 1H), 7.52 (s, 1H), 7.61 (d, 1H), 7.69 (d, 1H), 7.72 (d, 1H), 7.84 (m, 1H), 8.18 (d, 1H), 8.44 (m, 1H), 10.78 (s, 1H). 140 83 δppm 2.19 (s, 3H), 3.36 (q, 2H), 3.54 (q, 2H), 7.04 (s, 1H), 7.28 (d, 1H), 7.40 (d, 1H), 7.56 (q, 1H), 7.79 (d, 1H), 8.03 (m, 1H), 8.35 (d, 1H), 8.42 (m, 1H), 10.38 (s, 1H). 173 83 m.p. 136-138; δppm 2.35 (3H, s), 3.30 (2H, m), 3.50 (2H, m), 6.60 (1H, s), 6.78 (1H, m), 7.11 (1H, m), 7.27 (2H, m), 7.65 (1H, m), 7.82 (1H, m), 8.00 (2H, m), 8.45 (1H, d), 10.3 (1H, s). 179 83 m.p. 192-194; δppm 2.17 (3H, s), 3.33 (2H, m), 3.47 (2H, m), 6.56 (1H, m). 7.34 (1H, d), 7.36 (1H, d), 7.47 (1H, d), 7.57 (2H, m), 7.97 (1H, dd), 8.12 (1H, dd), 8.45 (2H, m), 10.3 (1H, s). 179 199 m.p. 99-101; δppm 1.66 (2H, t), 2.17 (3H, s), 3.19 (2H, m), 3.36 (2H, m), 6.53 (1H, m), 7.37 (1H, m), 7.48 (1H, s), 7.58 (2H, m), 7.96 (1H, d), 8.12 (1H, d), 8.37 (1H, m), 8.48 (1H, d). 179 304 m.p. 198-200; δppm 1.19 (3H, d), 2.19 (3H, s), 3.47 (2H, m), 4.15 (2H, m), 7.09 (1H, m), 7.34 (2H, m), 7.52 (1H, m), 7.67 (1H, m), 8.02 (1H, m), 8.21 (1H, d), 8.39 (1H, m), 8.41 (1H, m), 10.25 (1H, d). 180 303 δppm 2.08 (3H, s), 3.15 (4H, m), 3.62 (4H, m), 6.89 (1H, d), 7.29 (1H, s), 7.35 (1H, dd), 7.40 (1H, s), 7.45 (1H, s), 7.82 (1H,, d), 7.97 (1H, d), 8.23 (1H, d0, 8.44 (1H, s), 10.4 (1H, s). 181 83 m.p. 200-202; δppm 2.20 (3H, s), 3.34 (2H, m), 3.52 (2H, m), 7.09 (1H, m), 7.31 (2H, s), 7.37 (1H, s), 7.50 (1H, m), 7.74 (1H, m), 8.02 (1H, d), 8.24 (1H, s), 8.41 (2H, m), 10.3 (1H, s). 181 199 m.p. 129-130; δppm 1.83 (2H, m), 2.17 (3H, s), 3.44 (2H, m), 3.63 (2H, m), 5.82 (1H, m), 7.13 (1H, s), 7.25 (1H, m), 7.36 (2H, m), 7.49 (1H, m), 7.66 (1H, d), 7.82 (1H, dd), 8.21 (1H, s), 10.4 (1H, s). 181 303 m.p. 221-222; δppm 2.26 (3H, s), 3.24 (4H, m), 3.38 (4H, m), 7.20 (1H, s), 7.40 (2H, m), 7.45 (1H, m), 8.00 (2H, m), 8.34 (1H, d), 8.53 (1H, s), 10.33 (1H, s). 181 304 m.p. 105-107; δppm 1.13 (3H, d), 2.16 (3H, s), 3.37 (2H, m), 4.18 (2H, m), 6.55 (1H, dd), 7.23 (1H, m), 7.36 (2H, m), 7.46 (1H, m), 7.59 (2H, m), 7.96 (1H, d), 8.13 (2H, m), 8.46 (2H, m). 182 83 δppm 2.20 (s, 3H), 3.34 (q, 2H), 3.51 (q, 2H), 7.06 (s, 1H), 7.32 (d, 1H), 7.36 (d, 1H), 7.51 (q, 1H), 7.85 (d, 1H), 8.01 (m, 1H), 8.31 (d, 1H), 8.40 (m, 1H,), 10.26 (s, 1H). 182 199 δppm 1.84 (m, 2H), 2.21 (s, 3H), 3.44 (q, 2H), 3.64 (q, 2H), 6.20 (s, 1H), 6.98 (s, 1H), 7.04 (s, 1H), 7.32 (d, 1H), 7.36 (d, 1H), 7.38 (q, 1H), 7.66 (d, 1H), 7.84 (m 1H), 8.25 (d, 1H), 8.44 (m 1H), 0.10 (s, 1H) 211 83 δppm 2.04 (s, 3H), 3.60 (q, 2H), 3.68 (q, 2H), 5.62 (s, 1H), 7.04 (s, 1H), 7.22 (d, 1H), 7.30 (d, 1H), 7.38 (q, 1H), 7.54 (d, 1H), 7.84 (dd, 1H), 7.95 (d, 1H), 8.10 (s, 1H), 8.44 (m, 1H), 10.38 (s, 1H). 211 199 δppm 1.82 (m, 2H), 2.19 (s, 3H), 3.44 (q, 2H), 3.59 (q, 2H), 5.40 (s, 1H), 7.08 (s, 1H), 7.22 (d, 1H), 7.26 (d, 1H), 7.30 (d, 1H), 7.35 (q, 1H), 7.55 (s, 1H), 7.82 (m, 1H) 7.89 (d, 1H), 8.43 (m, 1H), 10.38 (s, 1H).

FORMULATION EXAMPLE Base on 100% Active Ingredient(Weight/Weight %) Example 4 60% Wettable Powders

Active ingredient 304 in Table 181 60%  Sodium dodecylnaphthalenesulfate 2% Sodium lignosulfonate 9% Kaolin make up to 100%

All solid components are well mixed and shattered until the particle size reaches the standard in order to obtain 60% wettable powder.

Example 5 5% Dusts

Active ingredient 304 in Table 179 5% Talc make up to 100%

All components are well mixed and the mixture is ground in a suitable mill to obtain 5% dusts.

Example 6 10% Extruder Granules

Active ingredient 83 in Table 181 10%  Sodium lignosulfonate 2% Carboxymethylcellulose 1% Kaolin make up to 100%

The active ingredient 83 in Table 181 is mixed with the additives, and the mixture is ground, moistened with water, extruded, granulated and dried in a stream of air.

Example 7 40% Suspension Concentrate

Active ingredient 199 in Table 181 40% Glycol 10% Nonylphenols polyethylene glycol ether  6% Sodium lignosulfonate 10% Carboxymethyl cellulose  1% 37% formaldehyde aqueous solution 0.2%  75% of silicone oil water emulsion 0.8%  Water make up to 100%

Compound 199 in Table 181 and other components are well mixed to obtain suspension concentrate, which can be diluted with water to give suspensions of any desired concentration.

Example 6 60% Water Dispersible Granules

Active ingredient 83 in Table 179 60%  Naphthalene sulfonate formaldehyde condensate 12%  N-methyl-N-oil acyl-bovine sodium 8% Polyvinylpyrrolidone 2% Carboxymethyl cellulose 2% Kaolin make up to 100%

Compound 83 in Table 179 is well mixed with other components, kneading together with water, which was added to the granulation 10-100 mesh machine for granulation, then dried and sieved (at the scope screen).

Biological Testing

Example 9 Determination of Fungicidal Activity

Determine the fungicidal activities of the compounds of the present invention against plant diseases, carried by following procedure:

Determination of Fungicidal Activity In Vivo:

Compounds were dissolved in acetone, and diluted to required concentration with water containing 0.1% of tween 80. Plants were sprayed by a sprayer. After 24 hours, plants were innoculated and then transferred into a dew chamber for infection. After the infection period normally one week), the plants were scored for disease control.

Part of the test results are as follows:

At 400 ppm, compound 83 in Table 96, compound 304 in Table 179, compound 83 in Table 181, compound 83 in Table 211 showed 100% control of cucumber anthracnose; compound 199 in Table 139, compound 83 and 199 in Table 211 showed more than 98% control of cucumber downy mildew; compound 303 and 107 in Table 96, compound 304 in Table 179 showed more than 70% control of grey mould.

At 50 ppm, compound 304 in Table 179, Table 181-83 showed 100% control of cucumber anthracnose.

At 25 ppm, compound Table 179-304, Table 181-83 showed more than 90% control of cucumber anthracnose.

Contrast compound chlorantraniliprole (rynaxypyr, DuPont) showed no fungicidal activity at 400 ppm.

Example 10 Determination of Insecticidal and Acaricidal Activity

Determination of insecticidal and acaricidal activity of selected compounds were carried out by following procedure:

Compounds were dissolved in mixed solvent (acetone:methanol=1:1), and diluted to required concentration with water containing 0.1% of tween 80.

The armyworm (Leucania separata), the second stage Juvenile of diamond backmoth (Plutella xylostella), lesser army worm (Spodoptera exiqua), green peach aphids (Myzus persicae) and mite (Tetranychus cinnabarinus) were used in biological test. The test was employed either spraying by airbrush. A test solution (0.5 ml) was sprayed at the pressure of 10 psi (0.7 kg/cm²). Percent mortality was determined after two to three days.

Part of Test Results:

At 600 ppm, compounds in Table 139-83, Table 139-199, Table 140-83, Table 173-83, Table 179-83, Table 179-199, Table 179-304, Table 179-303, Table 181-83, Table 181-199, Table 181-303, Table 181-304, Table 182-83, Table 182-199, Table 211-83, Table 211-199 showed 100% control of diamond backmoth and lesser armyworm.

At 10 ppm, compounds in Table 179-304, Table 181-83, Table 181-199, Table 211-199 showed 100% control of lesser armyworm; compounds in Table 139-83, Table 139-199, Table 182-83, Table 182-199, Table 211-83 showed more than 75% control of lesser armyworm.

At 1 ppm, compounds in Table 179-304, Table 181-83, Table 181-199 showed 100% control of lesser armyworm; compound Table 182-83, Table 182-199, Table 211-199 showed more than 50% control of lesser armyworm.

At 0.1 ppm, compounds in Table 181-83 showed more than 60% control of lesser armyworm. 

What is claimed is:
 1. An amide compounds compound having the general formula I:

wherein: R₁ and R₂ are each independently H, OH, halogen, CN, NO₂, C₁-C₄ alkyl, C₁-C₄ haloalkyl, C₁-C₄ alkoxyalkyl, COR₁₁, CO₂R₁₁, CONR₁₂R₁₁, C₁-C₄ alkoxy, C₁-C₄ haloalkoxy, NR₁₂R₁₁, NR₁₂COR₁₁, NR₁₂CO₂R₁₁, SO_(m)R₁₂, SO₂NR₁₂R₁₁, unsubstituted phenyl, or substituted phenyl with substituent group(s) being from 1 to 3, wherein the substituent group(s) is(are) each independently Cl, Br, F, CN, NO₂, C₁-C₆ alkyl, C₁-C₃ haloalkyl, C₁-C₃ haloalkoxy, or C₁-C₃ alkoxycarbonyl; m is 0, 1 or 2; R₃ and R₄ are each independently H, C₁-C₆ alkyl, C₂-C₆ alkenyl, C₂-C₆ alkynyl, C₃-C₆ cycloalkyl, or C₁-C₄ haloalkyl; X is (CHR₅)_(n); wherein n is an integer from 2 to 10; and wherein each R₅ is independently H, C₁-C₆ alkyl, C₂-C₆ alkenyl, C₂-C₆ alkynyl, C₃-C₆ cycloalkyl, or C₁-C₆ haloalkyl; G₁ is CR₆ or N; G₂ is CR₇ or N; G₃ is CR₈ or N; and wherein G₁, G₂, and G₃ cannot be N at the same time; R₆, R₇, and R₈ are each independently H, OH, halogen, CN, NO₂, C₁-C₄ alkyl, C₃-C₆ cycloalkyl, CONH₂, CONHCH₂CN, C₁-C₃ alkoxy, C₁-C₃ haloalkoxy, C₁-C₃ alkylthio, C₁-C₃ alkylsulfinyl, C₁-C₃ alkylsulfonyl, C₁-C₃ alkoxycarbonyl, C₁-C₃ alkylcarbonyl, C₁-C₃ alkylamino, C₂-C₆ dialkylamino, C₃-C₆ cycloalkylamino, unsubstituted phenyl, substituted phenyl with substituent group(s) being from 1 to 4, unsubstituted phenylamino, or substituted phenylamino with substituent group(s) being from 1 to 4, wherein the substituent group(s) is(are) each independently Cl, Br, F, CN, NO₂, C₁-C₄ alkyl, C₁-C₃ haloalkyl, C₁-C₃ alkoxy, C₁-C₃ haloalkoxy, or C₁-C₃ alkoxycarbonyl; R₉ is H, OH, halogen, CN, NO₂, C₁-C₄ alkyl, C₃-C₆ cycloalkyl, C₁-C₃ haloalkyl, C₁-C₃ alkoxyalkyl, C₁-C₃ alkoxy, C₁-C₃ haloalkoxy, COR₁₁, CO₂R₁₁, CONR₁₁R₁₂, NR₁₂R₁₁, NR₁₂COR₁₁, NR₁₂CO₂R₁₁, SO_(m)R₁₂, SO₂NR₁₂R₁₁, unsubstituted phenyl, substituted phenyl, unsubstituted pyrazolyl, substituted pyrazolyl, unsubstituted pyridyl, or substituted pyridyl, wherein the substituent group(s) being from 1 to 3 is(are) each independently halogen, CN, NO₂, C₁-C₄ alkyl, C₃-C₆ cycloalkyl, C₁-C₃ haloalkyl, C₁-C₃ alkoxyalkyl, C₁-C₃ alkoxy, C₁-C₃ haloalkoxy, COR₁₁, CO₂R₁₁, CONR₁₁R₁₂, NR₁₁R₁₂, NR₁₂COR₁₁, NR₁₂CO₂R₁₁, SO_(m)R₁₂, or SO₂NR₁₁R₁₂; t is 1, 2, 3, or 4; R₁₀ and R₁₁ are each independently H or C₁-C₄ alkyl; R₁₂ is H, C₁-C₄ alkyl, C₁-C₃ haloalkyl, unsubstituted phenyl, or substituted phenyl, wherein the substituent group is Cl, Br, F, CN, NO₂, C₁-C₄ alkyl, CF₃, OCH₃, OCF₃, or CO₂CH₃; Q is unsubstituted C₁-C₄ alkyl, substituted C₁-C₄ alkyl, unsubstituted cyclopropyl, or substituted cyclopropyl, wherein the substituent group(s) being from 1 to 4 is(are) each independently Cl, Br, F, C₁-C₄ alkyl, unsubstituted phenylamino, substituted phenylamino, unsubstituted C₂-C₄ alkenyl, or substituted C₂-C₄ alkenyl, wherein the substituent group(s) being from 1 to 3 is(are) each independently Cl, Br, F, C₁-C₄ alkyl, C₃-C₆ cycloalkyl, haloalkyl, C₁-C₄ alkoxy, C₁-C₄ haloalkoxy, or C₁-C₄ alkoxycarbonyl; or unsubstituted phenyl, substituted phenyl, unsubstituted pyrazolyl, substituted pyrazolyl, unsubstituted pyridyl, or substituted pyridyl, wherein the substituent group(s) being from 1 to 4 is(are) each independently halogen, CN, NO₂, C₁-C₄ alkyl, C₃-C₆ cycloalkyl, C₁-C₃ haloalkyl, C₁-C₃ alkoxyalkyl, C₁-C₃ alkoxy, C₁-C₃ haloalkoxy, COR₁₁, CO₂R₁₁, CONR₁₁R₁₂, NR₁₁R₁₂, NR₁₂COR₁₁, NR₁₂CO₂R₁₁, SO_(m)R₁₂, or SO₂NR₁₁R₁₂.
 2. The compound according to the claim 1, wherein general formula I: R₁ is H, OH, Cl, Br, F, NO₂, CN, CH₃, CH₂CH₃, tert-butyl, CF₃, CH₂CF₃, OCH₃, OCF₃, CONH₂, CONHCH₂CN, CO₂CH₃, or CO₂C₂H₅; R₂ is H, OH, Cl, Br, F, NO₂, CN, CH₃, CH₂CH₃, tert-butyl, cyclopropyl, CF₃, CH₂CF₃, OCF₃, OCH₂CF₃, CO₂CH₃, CO₂C₂H₅, unsubstituted phenyl, or substituted phenyl, wherein the substituent group(s) being from 1 to 3 is(are) each independently Cl, Br, F, CN, NO₂, CH₃, CH₂CH₃, tert-butyl, CF₃, CH₂CF₃, OCH₃, OCF₃, CO₂CH₃, or CO₂C₂H₅; R₃ and R₄ are each independently H or C₁-C₃ alkyl; X is (CHR₅)₆; wherein n is an integer selected from 2 to 10; and wherein each R₅ is independently H, C₁-C₃ alkyl, or C₁-C₃ haloalkyl; G₁ is CR₆ or N; G₂ is CR₇ or N; G₃ is CR₈ or N; and wherein G₁, G₂, and G₃ cannot be N at the same time; R₆, R₇, and R₈ are each independently H, OH, Cl, Br, F, CN, NO₂, CH₃, CH₂CH₃, tert-butyl, cyclopropyl, CF₃, CH₂CF₃, OCF₃, OCH₂CF₃, CO₂CH₃, CONH₂, CONHCH₂CN, C₁-C₃ alkylamino, C₂-C₄ dialkylamino, C₃-C₆ cycloalkylamino, unsubstituted phenyl, substituted phenyl with substituent group(s) being from 1 to 3, or unsubstituted phenylamino or substituted phenylamino with substituent group(s) being from 1 to 3, wherein the substituent group(s) is(are) each independently Cl, Br, I, CN, NO₂, CH₃, CH₂CH₃, tert-butyl, CHF₂, CF₃, CH₂CF₃, OCH₃, OCHF₂, OCF₃, CO₂CH₃, or CO₂C₂H₅; R₉ is H, Cl, Br, F, CN, NO₂, CH₃, tert-butyl, CHF₂, CF₃, OCH₃, OCHF₂, OCF₃, OCH₂CF₃, SO₂CH₃, C₁-C₃ alkylamino, or C₂-C₄ dialkylamino; t is 1, 2, 3, or 4; R₁₀ is H, CH₃, or C₂H₅; NR₁₀—CO-Q is at the 2, 3, or 4-position of benzene ring; Q is selected from one of the following groups:

wherein: R₁₃ is H, Cl, Br, F, CN, NO₂, NH₂, CH₃, CH₂CH₃, tert-butyl, cyclopropyl, CF₃, CH₂CF₃, OCH₃, OCF₃, OCH₂CF₃, SO₂CH₃, CO₂CH₃, C₁-C₃ alkylaminocarbonyl, C₂-C₄ dialkylaminocarbonyl, unsubstituted phenyl, substituted phenyl with substituent group(s) being from 1 to 3, unsubstituted pyridyl, or substituted pyridyl with substituent group(s) being from 1 to 3, wherein the substituent group(s) is(are) each independently H, Cl, Br, F, CN, NO₂, CH₃, CH₂CH₃, tert-butyl, cyclopropyl, CHF₂, CF₃, CH₂CF₃, OCH₃, OCHF₂, OCF₃, OCH₂CF₃, or SO₂CH₃; R₁₄ is H, CH₃, CH₂CH₃, tert-butyl, CF₃, CH₂CF₃, unsubstituted phenyl, substituted phenyl with substituent group(s) being from 1 to 3, unsubstituted pyridyl, or substituted pyridyl with substituent group(s) being from 1 to 3, the substituent group(s) is(are) each independently Cl, Br, F, CN, NO₂, CH₃, CH₂CH₃, tert-butyl, cyclopropyl, CHF₂, CF₃, CH₂CF₃, OCH₃, OCHF₂, OCF₃, OCH₂CF₃, or SO₂CH₃; p is 1 or
 2. 3. The compound according to the claim 2, wherein general formula I: R₁ is H, Cl, Br, F, NO₂, CN, CH₃, CH₂CH₃, tert-butyl, CF₃, CH₂CF₃, OCH₃, OCF₃, CO₂CH₃, or CO₂C₂H₅; R₂ is H, Cl, Br, F, NO₂, CN, CH₃, CH₂CH₃, tert-butyl, cyclopropyl, CF₃, CH₂CF₃, OCF₃, OCH₂CF₃, CO₂CH₃, CO₂C₂H₅, unsubstituted phenyl, or substituted phenyl with the substituent group(s) being from 1 to 3 is(are) each independently Cl, Br, F, CN, NO₂, CH₃, CH₂CH₃, tert-butyl, CF₃, CH₂CF₃, OCH₃, OCF₃, CO₂CH₃, or CO₂C₂H₅; R₃ and R₄ are each independently H, or C₁-C₃ alkyl; X is (CHR₅)_(n); wherein n is an integer selected from 2 to 10; and wherein each R₅ is independently H, C₁-C₃ alkyl, or C₁-C₃ haloalkyl; G₁ is CR₆ or N; G₂ is CR₇ or N; G₃ is CR₈ or N; and wherein G₁, G₂, and G₃ cannot be N at the same time; R₆, R₇, and R₈ are each independently H, Cl, Br, F, CN, NO₂, CH₃, CH₂CH₃, tert-butyl, cyclopropyl, CF₃, CH₂CF₃, OCF₃, OCH₂CF₃, CO₂CH₃, C₁-C₃ alkylamino, C₂-C₄ dialkylamino, cyclopropylamino, unsubstituted phenyl, substituted phenyl with substituent group(s) being from 1 to 3, unsubstituted phenylamino, or substituted phenylamino with substituent group(s) being from 1 to 3, the substituent group(s) is(are) each independently Cl, Br, I, CN, NO₂, CH₃, CH₂CH₃, tert-butyl, CHF₂, CF₃, CH₂CF₃, OCH₃, OCHF₂, OCF₃, CO₂CH₃, or CO₂C₂H₅; R₉ is H, Cl, Br, F, CN, NO₂, CH₃, CHF₂, CF₃, OCH₃, OCHF₂, OCF₃, OCH₂CF₃, or SO₂CH₃; t is 1, 2, 3, or 4; R₁₀ is H, CH₃, or C₂H₅; NR₁₀—CO-Q is at the 2, 3, or 4-position of benzene ring; Q is selected from one of the following groups:

wherein: R₁₃ is H, Cl, Br, F, CN, NO₂, CH₃, CH₂CH₃, tert-butyl, cyclopropyl, CF₃, CH₂CF₃, OCH₃, OCF₃, OCH₂CF₃, SO₂CH₃, CO₂CH₃, unsubstituted phenyl, substituted phenyl with substituent group(s) being from 1 to 3, unsubstituted pyridyl, or substituted pyridyl with substituent group(s) being from 1 to 3, the substituent group(s) is(are) each independently H, Cl, Br, F, CN, NO₂, CH₃, CH₂CH₃, tert-butyl, cyclopropyl, CHF₂, CF₃, CH₂CF₃, OCH₃, OCHF₂, OCF₃, OCH₂CF₃, or SO₂CH₃; R₁₄ is H, CH₃, CH₂CH₃, tert-butyl, CF₃, CH₂CF₃, unsubstituted phenyl, substituted phenyl with substituent group(s) being from 1 to 3, unsubstituted pyridyl, or substituted pyridyl with substituent group(s) being from 1 to 3 the substituent group(s) is(are) each independently Cl, Br, F, CN, NO₂, CH₃, CH₂CH₃, tert-butyl, cyclopropyl, CHF₂, CF₃, CH₂CF₃, OCH₃, OCHF₂, OCF₃, OCH₂CF₃, or SO₂CH₃; p is 1 or
 2. 4. The compound according to the claim 3, wherein general formula I: R₁ is H, Cl, Br, F, NO₂, CN, CH₃, tert-butyl, CF₃, OCH₃, or OCF₃; R₂ is H, Cl, Br, F, NO₂, CN, CH₃, tert-butyl, cyclopropyl, CF₃, OCF₃, CO₂CH₃, or CO₂C₂H₅; R₃ and R₄ are each independently H or C₁-C₃ alkyl; X is —CH₂CH₂—, —CH₂CH₂CH₂—, —CH(CH₃)CH₂—, —CH(C₂H₅)CH₂—, —CH₂(CH₂)₂CH₂—, —CH₂(CH₂)₃CH₂—, —CH₂(CH₂)₄CH₂—, —CH₂(CH₂)₅CH₂—, —CH₂(CH₂)₆CH₂—, —CH₂(CH₂)₇CH₂—, or —CH₂(CH₂)₈CH₂—; G₁ is CR₆ or N; G₂ is CR₇ or N; G₃ is CR₈ or N; and wherein G₁, G₂, and G₃ cannot be N at the same time; R₆, R₇, and R₈ are each independently H, Cl, Br, F, CN, NO₂, CH₃, CH₂CH₃, tert-butyl, cyclopropyl, CF₃, CH₂CF₃, OCF₃, OCH₂CF₃ or CO₂CH₃; R₉ is H, Cl, Br, F, CN, NO₂, CH₃, CHF₂, CF₃, OCH₃, OCHF₂, OCF₃, OCH₂CF₃, or SO₂CH₃; t is 1, 2, 3, or 4; R₁₀ is H; NR₁₀—CO-Q is at the 2, 3, or 4-position of benzene ring; Q is selected from one of the following groups:

wherein: R₁₄ is H, CH₃, unsubstituted phenyl, substituted phenyl with substituent group(s) being from 1 to 3, unsubstituted pyridyl, or substituted pyridyl with substituent group(s) being from 1 to 3, wherein the substituent group(s) is(are) each independently Cl, Br, F, CN, NO₂, CH₃, CH₂CH₃, tert-butyl, CF₃, OCH₃, or OCF₃; when R₁₄ is H or CH₃, R₁₃ is H, Cl, Br, F, CN, CH₃, CH₂CH₃, tert-butyl, cyclopropyl, CF₃, OCH₃, OCF₃, OCH₂CF₃, SO₂CH₃, unsubstituted phenyl, or substituted phenyl, the substituent group is H, Cl, Br, F, CN, NO₂, CH₃, CH₂CH₃, tert-butyl, CHF₂, CF₃, OCH₃, OCHF₂, OCF₃, OCH₂CF₃, or SO₂CH₃; when R₁₄ is (un)substituted phenyl or pyridyl, R₁₃ is H, Cl, Br, F, CN, CH₃, CH₂CH₃, tert-butyl, cyclopropyl, CF₃, OCH₃, OCF₃, OCH₂CF₃, or SO₂CH₃; and p is 1 or
 2. 5. The compound according to the claim 4, wherein general formula I: R₁ is H, Cl, Br, F, NO₂, CN, CH₃, or CF₃; R₂ is H, Cl, Br, F, NO₂, CN, CH₃, tert-butyl, cyclopropyl, CF₃, OCF₃, CO₂CH₃, or CO₂C₂H₅; R₃ and R₄ are each independently H; X is —CH₂CH₂—, —CH₂CH₂CH₂—, —CH(CH₃)CH₂—, —CH(C₂H₅)CH₂—, —CH₂(CH₂)₂CH₂—, —CH₂(CH₂)₃CH₂—, —CH₂(CH₂)₄CH₂—, —CH₂(CH₂)₅CH₂—, —CH₂(CH₂)₆CH₂—, —CH₂(CH₂)₇CH₂—, or —CH₂(CH₂)₈CH₂—; G₁ is CR₆ or N; G₂ is CR₇ or N; G₃ is CR₈ or N; and wherein G₁, G₂, and G₃ cannot be N at the same time; R₆, R₇, and R₈ are each independently H, Cl, Br, F, CN, NO₂, CH₃, CH₂CH₃, tert-butyl, cyclopropyl, CF₃, OCH₃, or CO₂CH₃; R₉ is H, Cl, Br, F, CN, NO₂, CH₃, CHF₂, CF₃, OCH₃, OCHF₂, OCF₃, OCH₂CF₃, or SO₂CH₃; t is 1 or 2; R₁₀ is H; NR₁₀—CO-Q is at the 2 or 4-position of benzene ring; Q is the following pyrazolyl group:

wherein: R₁₄ is H, CH₃, unsubstituted phenyl, substituted phenyl with substituent group(s) being from 1 to 3, unsubstituted pyridyl, or substituted pyridyl both with substituent group(s) being from 1 to 3, the substituent group(s) is(are) each independently Cl, Br, F, CN, NO₂, CH₃, CH₂CH₃, tert-butyl, CF₃, OCH₃, or OCF₃; when R₁₄ is H or CH₃, R₁₃ is H, Cl, Br, F, CN, CH₃, CH₂CH₃, tert-butyl, CF₃, OCH₃, OCF₃, SO₂CH₃, unsubstituted phenyl, or substituted phenyl with substituent group, the substituent group is H, Cl, Br, F, CN, NO₂, CH₃, CH₂CH₃, tert-butyl, CHF₂, CF₃, OCH₃, OCHF₂, OCF₃, or SO₂CH₃; when R₁₄ is (un)substituted phenyl or pyridyl, R₁₃ is H, Cl, Br, F, CN, CH₃, CH₂CH₃, tert-butyl, CF₃, OCH₃, OCF₃, or SO₂CH₃; p is 1 or
 2. 6. A process for preparing the compound having general formula I according to claim 1, which comprises reacting an amine group compound having general formula IV with substituted benzoxazinone having general formula V-A or aromatic acid chloride having general formula V-B in the presence of base:

wherein: L is leaving group, which is Cl or Br; R₁ and R₂ are each independently H, OH, halogen, CN, NO₂, C₁-C₄ alkyl, C₁-C₄ haloalkyl, alkoxyalkyl, COR₁₁, CO₂R₁₁, CONR₁₂R₁₁, alkoxy, C₁-C₄ haloalkoxy, NR₁₂R₁₁, NR₁₂COR₁₁, NR₁₂CO₂R₁₁, SO_(m)R₁₂, SO₂NR₁₂R₁₁, unsubstituted phenyl, or substituted phenyl, wherein the substituent group is Cl, Br, F, CN, NO₂, C₁-C₆ alkyl, C₁-C₃ haloalkyl, C₁-C₃ haloalkoxy, or C₁-C₃ alkoxycarbonyl; m is 0, 1, or 2; R₃ and R₄ are each independently H, C₁-C₆ alkyl, C₂-C₆ alkenyl, C₂-C₆ alkynyl, C₃-C₆ cycloalkyl, or C₁-C₄ haloalkyl; X is (CHR₅)_(n); wherein n is an integer selected from 2 to 10; and wherein each R₅ is independently H, C₁-C₆ alkyl, C₂-C₆ alkenyl, C₂-C₆ alkynyl, C₃-C₆ cycloalkyl or C₁-C₆ haloalkyl; G₁ is CR₆ or N; G₂ is CR₇ or N; G₃ is CR₈ or N; and wherein G₁, G₂, and G₃ cannot be N at the same time; R₆, R₇, and R₈ are each independently H, OH, halogen, CN, NO₂, C₁-C₄ alkyl, C₃-C₆ cycloalkyl, CONH₂, CONHCH₂CN, C₁-C₃ alkoxy, C₁-C₃ haloalkoxy, C₁-C₃ alkylthio, C₁-C₃ alkylsulfinyl, C₁-C₃ alkylsulfonyl, C₁-C₃ alkoxycarbonyl, C₁-C₃ alkylcarbonyl, C₁-C₃ alkylamino, C₂-C₆ dialkylamino, C₃-C₆ cycloalkylamino, unsubstituted phenyl, substituted phenyl with substituent group(s) being from 1 to 4, unsubstituted phenylamino, or substituted phenylamino with substituent group(s) being from 1 to 4, the substituent group(s) is(are) each independently Cl, Br, F, CN, NO₂, C₁-C₄ alkyl, C₁-C₃ haloalkyl, C₁-C₃ alkoxy, C₁-C₃ haloalkoxy, or C₁-C₃ alkoxycarbonyl; R₉ is H, OH, halogen, CN, NO₂, C₁-C₄ alkyl, C₃-C₆ cycloalkyl, C₁-C₃ haloalkyl, C₁-C₃ alkoxyalkyl, C₁-C₃ alkoxy, C₁-C₃ haloalkoxy, COR₁₁, CO₂R₁₁, CONR₁₁R₁₂, NR₁₂R₁₁, NR₁₂COR₁₁, NR₁₂CO₂R₁₁, SO₂NR₁₂R₁₁, unsubstituted phenyl, substituted phenyl with substituent group(s) being from 1 to 3, unsubstituted pyrazolyl, substituted pyrazolyl with substituent group(s) being from 1 to 3, unsubstituted pyridyl, or substituted pyridyl with substituent group(s) being from 1 to 3, wherein the substituent group(s) is(are) each independently halogen, CN, NO₂, C₁-C₄ alkyl, C₃-C₆ cycloalkyl, C₁-C₃ haloalkyl, C₁-C₃ alkoxyalkyl, C₁-C₃ alkoxy, C₁-C₃ haloalkoxy, COR₁₁, CO₂R₁₁, CONR₁₁R₁₂, NR₁₁R₁₂, NR₁₂COR₁₁, NR₁₂CO₂R₁₁, SO_(m)R₁₂, or SO₂NR₁₁R₁₂; t is 1, 2, 3 or 4; R₁₀ and R₁₁ are each independently H or C₁-C₄ alkyl; R₁₂ is H, C₁-C₄ alkyl, C₁-C₃ haloalkyl, unsubstituted phenyl, or substituted phenyl, wherein the substituent group is Cl, Br, F, CN, NO₂, C₁-C₄ alkyl, CF₃, OCH₃, OCF₃, or CO₂CH₃; Q is unsubstituted C₁-C₄ alkyl, substituted C₁-C₄ alkyl with substituent group(s) being from 1 to 4, unsubstituted cyclopropyl, or substituted cyclopropyl with substituent group(s) being from 1 to 4, wherein the substituent group(s) is(are) each independently Cl, Br, F, C₁-C₄ alkyl, unsubstituted phenylamino, substituted phenylamino with substituent group(s) being from 1 to 3, unsubstituted C₂-C₄ alkenyl, or substituted C₂-C₄ alkenyl with substituent group(s) being from 1 to 3, wherein the substituent group(s) is(are) each independently Cl, Br, F, C₁-C₄ alkyl, C₃-C₆ cycloalkyl, C₁-C₄ haloalkyl, C₁-C₄ alkoxy, C₁-C₄ haloalkoxy, or C₁-C₄ alkoxycarbonyl; unsubstituted phenyl, substituted phenyl with substituent group(s) being from 1 to 3, unsubstituted pyrazolyl, substituted pyrazolyl with substituent group(s) being from 1 to 3, unsubstituted pyridyl, or substituted pyridyl with substituent group(s) being from 1 to 3, in which wherein the substituent group(s) is(are) each independently halogen, CN, NO₂, C₁-C₄ alkyl, C₃-C₆ cycloalkyl, C₁-C₃ haloalkyl, C₁-C₃ alkoxyalkyl, C₁-C₃ alkoxy, C₁-C₃ haloalkoxy, COR₁₁, CO₂R₁₁, CONR₁₁R₁₂, NR₁₁R₁₂, NR₁₂COR₁₁, NR₁₂CO₂R₁₁, SO_(m)R₁₂, or SO₂NR₁₁R₁₂.
 7. A method of controlling fungi which comprises applying the compound having general formula I according to claim 1 to agricultural and other fields.
 8. A method of controlling insects which comprises applying the compound having general formula I according to claim 1 to agricultural and other fields.
 9. An insecticidal or fungicidal composition comprising the compound having general formula I according to the claim 1 as an active ingredient, wherein the weight percentage of the active ingredient in the composition is in the range of 0.1-99%. 